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A comprehensive summary of the work to be incorporarated in the thesis entitled
“STUDIES ON MEDICINALLY INTERESTING CHEMICAL ENTITIES”
included investigation pertaining to 1,2,4-triazole and phenylamino derivatives, which
have been described as under.
[A] STUDIES ON TRIAZOLE DERIVATIVES
[B] STUDIES ON PHENYLAMINO DERIVATIVES
[A] STUDIES ON TRIAZOLE DERIVATIVES
1,2,4-Ttiazole and their derivatives constitute an important class of organic
compounds with diverse agricultural, industrial and biological activities. The synthesis of
these heterocycles has received considerable attention in recent years. Five membered
ring bearing three nitrogen atoms is known as triazole. The chemistry of 1,2,4-triazole
has assumed importance because of their versatility in the synthesis of many heterocyclic
compounds.
With a view to supplement of these valid observations and to evaluate its
pharmacological profiles, it was thought worthwhile to synthesized some new heterocycles
bearing 1,2,4-triazole nucleus, which have been described as under.
PART-I  :  STUDIES ON 1,3,4-THIADIAZOLE DERIVATIVES
The synthesis of compounds incorporating 1,3,4-thiadiazole rings has been
attracted widespread attention due to their diverse pharmacological properties like
antibiotic, antifungal, herbicidal, antitubercular,  etc. To approach this goal synthesis of
some 1,3,4-thiadiazole have been undertaken, which have been described as under.
SECTION-I  :  Synthesis and biological evaluation of 3-(m-chlorophenyl)-
    6-aryl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles
Synopsis...
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1,3,4-Thiadiazole derivatives of Type (I) have been synthesized by the
condensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different
aromatic acids in the presence of POCl3.
SECTION-II  :  Synthesis and biological evaluation of 3-(m-chlorophenyl)-6-
       aryl-5,6-dihydro[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles
1,3,4-Thiadiazole derivatives of Type(II) have been synthesized by the
condensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different
aromatic aldehydes in the presence of p-toluenesulphonic acid.
PART-II  :  STUDIES ON 4-ARYLTRIAZOLE DERIVATIVES
4-Aryltriazole derivatives have been found to be potent drug which possess a
wide spectrum of biological activity. Different types of 1,2,4-triazole derivatives shows
variety of pharmacological activities such as antidepressant, anti-inflammatory, biocides,
etc. Considering the increasing importance of compounds bearing 1,2,4-triazole nucleus,
N N
N
Cl
N
S
R
N N
N
Cl
N
H
S
R
R = Aryl
R = Aryl
Type (I)
Type (II)
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some new 1,2,4-triazole derivatives have been synthesized described as under.
SECTION-I  :  Synthesis and biological evaluation of 5-(m-chlorophenyl)-
    4-aryl-4H-1,2,4-triazole-3-thiols
4-Aryltriazole derivatives of Type(III) have been synthesized by reaction of
potassium-m-chlorobenzyl dithiocarbamate  with different aromatic amines.
PART-III  :  STUDIES ON THIADIAZINES
Literature survey reveals that various 1,3,4-thiadiazines have resulted in many
potential drugs and known to exhibit a broad spectrum of biological activities such as
antibacterial, cardiovascular, antifungal, antitubercular, etc. Hence it was considered
worthwhile to synthesized 1,3,4-thiadiazine derivatives for better drug potential, which
have been described as under.
SECTION-I  :  Synthesis and biological evaluation of 3-(m-chlorophenyl)-
    6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines
N N
N
Cl
SH
R
R = ArylType (III)
N N
N
Cl
N
S
R
R = ArylType (IV)
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Thiadiazines of Type (IV) have been synthesized by the condensation of 4-amino-
5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol  with different substituted phenacyl
bromides.
PART-IV  :  STUDIES ON THIADIAZEPINES
Seven membered rings containing sulfur and two nitrogen atoms exhibit wide
spectrum of biological activities such as anticancer, antibacterial, anti HIV, and
antitubercular. In order to develop compounds with better drug potential, it was
considered of interest to synthesize some new thiadiazepines, which have been described
as under.
SECTION-I  :  Synthesis and biological evaluation of 3-(m-chlorophenyl)-
                   9-alkyl[1,2,4]triazolo[3’,4’:2,3][1,3,4]thiadiazepino[6,7-b]quinolines
The compounds of Type (V) have been prepared by the condensation of 4-amino-
5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with substituted 2-chloro-3-formylquinolines,
which have been prepared by Wielsmayerhacck rearrangement.
PART-V  :  STUDIES ON SULPHONAMIDES
Sulphonamide derivatives have been reported to be associated with diverse
biological activities such as herbicidal, antihypertensive, anticonvulsant, antiviral,
antimalarial, anticancer and antimicrobial. With a view to getting better therapeutic
N N
N
Cl
N
N
R
S
Type (V) R = Aryl
Synopsis...
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agent and to evaluate its pharmacological profile, different type of sulphonamides have
been prepared, which have been described as under.
SECTION-I  :  Synthesis and biological evaluation of  [3-(m-chlorophenyl)-
    5-mercapto-4H-1,2,4-triazol-4-yl]arylsulfonamides
Sulphonamide derivatives of Type (VI) have been synthesized by the
condensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol  with different
carboxyaryl sulphonyl chloride.
PART-VI  :  STUDIES ON ARYL AMIDES
Substituted aryl amide shows different biological activities like antipyretic,
analgesic, antiseptic, antimoebic etc. To attempt to develop a potentially bioactive agents
synthesis of some new aryl amides have been undertaken, which have been described as
under.
SECTION-I  :  S y n t h e s i s  a n d  b i o l o g i c a l  e v a l u a t i o n  o f   [ 3 - ( m-
    chlorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl]arylamides
N N
N
Cl
SH
NH S
R
O
O
R = ArylType (VI)
N N
N
Cl
SH
NH
R
O
Type (VII) R = Aryl
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Arylamide derivatives of type (VII) have been synthesized by the condensation
of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different aromatic acid
chlorides.
PART-VII  :  STUDIES ON MANNICH BASES
Mannich bases containing bridged N-atom exhibit pronounced biological
activities. They possess diverse pharmacological action like antibacterial, antimalarial
and analgesic. Hence it is pertinent to synthesize some novel mannich bases, which have
been described as under.
SECTION-I  :  Synthesis and biological evaluation of 5-(m-chlorophenyl)-
    4-{[(1E)-(4-aryl)methylene]amino}-4H-1,2,4-triazole-3-thiols
The synthesis of schiff’s bases (VIII) have been undertaken by the condensation
of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different aromatic
aldehyde in the presence of sulphuric acid.
SECTION-II  :  Synthesis and biological evaluation of 5-(m-chlorophenyl)-
     2 - { [ ( 4 - s u b s t i t u t e d ) a m i n o ] m e t h y l } - 4 - { [ ( 1 -E ) - ( 4 -
     aryl)methylene]amino}-2,4-dihydro-3H-1,2,4-triazole-3-thiones
N N
N
Cl
N
CH
R
SH
Type (VIII) R = Aryl
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Mannich bases of type (IX) have been synthesized by the condensation of Schiff
bases of type (VIII) with different secondary amines and formaldehyde.
PART-VIII  :  STUDIES ON OXADIAZOLES
1,3,4- Oxadiazoles are associated with broad spectrum of pharmacological activity
like anesthetic, hypnotic, antibacterial, hypoglycemic and antifungal. These valid
observations promoted us to synthesis 1,3,4- oxadiazole derivatives with better
therapeutic value have been described as under.
SECTION-I  :  Synthesis and biological evaluation of 2-(m-chlorophenyl)-
    5-aryl-1,3,4-oxadiazoles
N N
N
Cl
N
R
S
N
R1
R2
Type (IX) R = Aryl
N N
O
Cl
R
  Type (X)   R = Aryl
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Oxadiazoles of type (X) have been synthesized by the cyclo condensation of m-
chlorobenzohydrazide with different aromatic acids in the presence of POCl3.
[B] STUDIES ON PHENYLAMINO DERIVATIVES
The 4-phenylamino derivatives are important class of organic compounds with
diverse range of biological activities. Many examples of biologically active molecules
are known which possessing 4-phenylamno nucleus.
In order to develop better medicinally interesting compounds, it was considered
of interest to synthesize some new 4-phenyhlamino derivatives as described under.
SECTION-I  :  S y n t h e s i s  a n d  b i o l o g i c a l  e v a l u a t i o n  o f  4 -(aryl amino)
    pent-3-en-2-one s
Phenylamino derivatives represents one of the modest class of compounds
possessing wide range of therapeutic activities such as antibiotic, antifungal, herbicidal,
insecticidal, antitubercular etc. To approach this goal synthesis of some phenylamino
derivatives have been undertaken, which described as under.
Phenylamino derivatives of type (XI) have been synthesized by the condensation
of acetyl acetone with different aromatic amines in the presence of pyridine.
SECTION-II  : X-ray crystallographic study of 4-(2-hydroxy
    phenylamino)pent-3-en-2-one
NH
O
CH3
CH3
R
  Type (XI)          R = Aryl
Synopsis...
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Single crystal x-ray diffraction is the most common experimental method of
obtaining a detailed picture of a small molecule that allows resolution of individual atoms.
Single crystal of 4-(2-hydroxy phenylamino)pent-3-en-2-one were grown by slow
evaporation technique at constant temperature using methanol as a solvent. Good quality
single crystals were harvested within 45days. The crystals are exhibiting photo conducting
nature.
In vitro study on multiple biological activities:
All the compounds have been evaluated for their antibacterial activity  towards
Gram +ve and Gram -ve bacterial strains and antifungal activity towards  Aspergillus
niger at a concentration 40 mg/ml. The biological activities of the  synthesized compounds
have been compared with standard drugs.
Some of the selected compounds have been sent to Tuberculosis  Antimicrobial
Acqistion Coordinating Facility (TAACF) Alabama, USA, for antimicrobial  data of
synthesized compound. The compounds have been screened for their in vitro biological
assay like antitubercular activity towards a strain of Mycobacterium tuberculosis
H37Rv at a concentration of 6.25 mg/ml using Rifampin as a standard drug.
Synopsis...
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INTRODUCTION
The starting point for every medicinal chemistry project is a lead compound with
a given pharmaceutical activity. However, the biological activity of a molecule must be
complemented by other properties that make the molecule a good drug. It is estimated
that a large proportion of molecules fails in late stage of drug development due to drug-
drug interaction or poor ADME (adsorption, distribution, metabolism and excretion)
features. Not detecting these liabilities early in the drug discovery process can be
extremely costly and time consuming. The aim of medicinal chemistry has shifted from
activity to selectivity. The more selective a compound is for a particular target the more
effective it is likely to be and the fewer the side effects it will have.  Medicinal chemistry
concerns the discovery, the development and the identification of action of biologically
active compound at the molecular level. Emphasis is put on drugs, but the interest of the
medicinal chemistry is also concerned with the study, identification and synthesis of
metabolic products of drugs and related compounds.
Drugs are chemicals of low molecular weight (~ 100-500) which interact with
macromolecular targets to produce a biological response. The biological response may
be therapeutically useful in the case of medicines or harmful in the case of poisons. Most
drugs used in medicine are potential poisons if taken in higher doses than recommended.
Heterocyclic compounds have great applicability in pharmaceutics because they
have specific chemical reactivity. The majority of synthetic heterocyclic compounds have
found widespread use, for example as anticancer agents, antitubercular, analeptics,
analgesic, hypnotics and as pesticides, insecticides and weed killers. Various synthetic
procedures have been developed and considerable diversity in the ring is achieved.
Heterocyclic compounds are enormous, their chemistry is complex and synthesizing them
requires great skill.
Modern medicinal chemistry began in the 1950s when organic chemists began to
apply newly developed steric and electronic structure active relationship of the steroids.
Introduction...
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The interesting medicinal activities of heterocyclic compounds have stimulated
considerable research work in recent years leading to the synthetic utility. Taking in a
view of the applicability of heterocyclic compounds, we have undertaken the preparation
of heterocycles bearing triazole nucleus. The placement of a wide variety of substituents
of these nuclei have been designed in order to evaluate the synthesized products for
their pharmacological profile against several strains of bacteria and fungi.
During the second half of the twentieth century, chemistry and biology made possible
the discovery of a steady stream of important new medicines. Chemistry contributed
these discoveries through impactful advantages in both theory and practice of this art/
science. Notable examples include in valuable advances in physical measurements,
computational techniques, inorganic catalysis, stereochemical control of synthesis and
the application of physical organic chemical concepts, typified by the transition state
analog principle, to enzyme inhibitor design. At the same time biology continued to
contribute through the discoveries at a rate that may well be termed explosive.
Introduction...
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AIMS AND OBJECTIVES
In the medicinal field, there has always been and will continue to be a need
for new and novel chemical inhibition of biological fraction. Our efforts are focused
on the molecular frame work in order to synthesizing medicinally interesting
compounds of widely different composition.
 During the course of research work, looking to the applications of the heterocyclic
compounds, several entities have been designed, generated and characterized using
spectral studies.
1. To generate several derivatives like thiadiazoles,thiadiazines, thiadiazepines,
 aryltriazoles, sulphonamides, arylamides bearing  1,2,4-triazole as a basic
            moiety.
2. To synthesize phenylamino derivatives and characterized by X-ray
 crystallography of that  compounds.
3. To characterize these all products for structure elucidation using spectroscopic
techniques like IR, NMR and Mass spectral studies.
4. To check the purity of all compounds using thin layer chromatography.
5. To evaluate these new products for better drug potential against different
strains of bacteria and fungi.
6. Selected compounds have been sent to “ Tuberculosis Antimicrobial
Acquisition and Co-ordinating Facility” (TAACF), Southern Research
institute, U.S.A. for their in vitro antitubercular screening.
Introduction...
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STUDIES ON
1,2,4-TRIAZOLES
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INTRODUCTION
Triazoles are well known five membered heterocyclic compounds and several
procedures for their synthesis have been extensively studied. Such studies have
been stimulated by various promising applications, especially in the case of nitrogen
containing heterocyclic entities. In fact, certain nitrogen containing heterocycles
are used as pharmaceuticals e.g. analgesic, anti-inflammatory, antipyretic,
agrochemicals where as some other is being studied for their medicinal interest.
The knowledge of such applications has pointed out that nitrogen containing
heterocycles are important target to be prepared to our research on medicinally
interesting chemical entities.
Triazoles have occupied an important place in the drug industry. Triazoles
are of two types 1,2,3-triazole (I) and 1,2,4-triazole (II).
                  ?-Triazole or 1,2,3-Triazole (I)
                          s-Triazole or 1,2,4-Triazole (II)
Hoggarth1 and Meyer
2 have been studied briefly with the chemistry of 1,2,4-triazoles.
Bladin3,4 is a pioneer scientist in the field of triazole, who had synthesized the first derivative of
1,2,4-triazole in 1885. 1,2,4-triazole derivatives not only known for their medicinal applications,
but they are also used as analytical reagents5, dyes and photographic chemicals6, corrosion
inhibitors
7,8
 and in the preparation of polymers
9
.
N
H
N
N
N
NH
N
N
H
N
N
N
N
H
N
N
N
NH
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SYNTHETIC ASPECT
Several methods have been reported in the literature for the synthesis of 1,2,4-
triazoles. The starting material for the synthesis of triazoles is thiosemicarbazide or
dithiocarbamate derivatives having nitrogen containing functions. The procedures for
synthesizing 1,2,4-triazoles have been described as under.
1. Reid and heindel10  reported that the reaction of aryl acid hydrazide with CS
2
/
KOH and hydrazine hydrate yields triazoles.
 (III)
2.        Chande et al. 11  have synthesized 4-amino 5-mercapto-s-triazoles from a
              a-acyldithio carbazinate and phenyl hydrazine at 140-160oC.
   (IV)
3.        Ivanka Kolenc et al. 12  synthesized 6-chloro-1,2,4-triazolo [4,3-b] pyridazin
from 3-chloro-6-hydrazino pyridazin in the presence of bis-o-(diehoxymethyl)
dimethyl glyoxime.
  (V)
NN
Cl NH
NH2 NN
Cl
NH
N
R
NH
NH2
O
CS2
KOH
R
NH
NH
O
S
-
S
K
+
NH 2.NH2.H2O
N
N N
SHR
NH2
R
NH
NH
O
S
-
S
K
+
C6H5NH.NH 2
140°-160° C N
N N
SHR
NH 2
H5C6
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4.        C. S. Andotra and Sukhbinder Kaur 13  synthesized triazole pyrimidine by the
reaction of aromatic acid with substituted hydrazino pyrimidines.
                                                                                              (VI)
5.           Yan Shiquaing
14  reported 3,4-disubstituted-4H-1,2,4-triazole-5-thiol (VI) from
the reaction of ferrocenecarboxylic acid hydrazide with aryl isothiocyanate.
                                                     (VII)
6.         Ver shilov and coworkers15  have synthesized 3-perfluoro substituted 1,2,4-
triazolyl-5-amines and 5-thiols by the reaction of RCOF with NH2-NH-CX-
NH2 (X=NH,S) to give RCONHNHCXNH2  followed by intramolecular
cyclization.
           R= C
6
H
13
, C
3
H
7
O, C
3
H
6
O
           Y= NH
2
, SH
                                     (VIII)
7.       Triazole nucleus can be also synthesized by the reaction of thiosemi carbazide
with formic acid in the presence of acetic anhydride16 .
    (IX)
N
N R1
NH
NH2
R
OHR2
O
N
N
N
N
R2
R1
R
N
N N
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Ph
N
N N
H
yR
N
N NH
R1
R
N
S R2
NH2 HCOOH
AC2O N
N
R1
R
N NH
N
S
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8.     L.Labanauskas et al. 17  have prepared triazoles by the addition reaction of
thiosemicarbazide with substituted benzoyl chloride in the presence of pyridine.
Then the substituted thiosemicarbazide cyclised in water in the presence of alkaline
catalyst.
9.       Abbas Shafiee et al. 18  have prepared 3-amino-5-[4-chloro -2-(2-chlorophenoxy)
phenyl]-4H-1,2,4-triazole from 4-chloro -2-(2-chlorophenoxy) benzoic acid by
reaction with SOCl
2
 and amino guanidine hydrogen carbonate in the presence of
alkaline catalyst.
(XI)
BIOLOGICAL IMPORTANCE
 Triazoles are potential bioactive agents due to their wide spectrum of therapeutic
importance. Drug molecules having 1,2,4-triazole nucleus with good activity are listed
as under.
NH
NH NHR 1
S
O
R
Alkaline
Catalyst N
N N
H
S
R1
R
COOH
Cl O
Cl
Alkaline
Catalyst
N
H
N N
NH2
O
Cl
Cl
 (X)
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1.  Estazolam 2. Letrozole
  Receptor Agonist       Antineoplastic
3.  Fluotrimazole 4.  Rifavirin
Fungicide Antiviral, Antiinfection
5.  Triazolam 6.  Triadimenol
      Fungicide
N
N
N
N
Cl
N
N
N
N N
N
N
N
CF3
N
N
N
ONH2
O
OH
OH
OH
N
N
N
N
CH3
Cl
Plant growth regulator
N N
N
O
CO
Cl
CH3
CH3
CH3
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7.  Azaconazole 8.  Rilmazafone
Antifungal Sedative, hypnotic
9.  Azocyclotin 10.  Amitrole
Antithyroid activity
Pesticide
Literature survey reveals that various 1,2,4-triazole derivatives display significant
biological activities. 3-Amino-1,2,4-triazole was the first 1,2,4-triazole to be
manufactured on large scale from aminoguanidine formate, useful as herbicides.1 9
Therapeutic activity of 1,2,4-triazoles are as under.
1. Bactericidal20
2. Diuretic21
3. Fungicidal22
4. Herbicidal23
5. Insecticidal and acaricidal24
Sn N
N
N
O
O
N
N
N
Cl
Cl
N
N
N
Cl
O
Cl
N
CH3
CH3
O
N
N
H
N
NH2
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Yaseen A.et al.36  have prepared 1,5-dialkyl-3-(5-mercapto-4-N-aryl-1H-1,2,4-
triazol-3-yl-methylene)-1H-1,2,4-triazole which exhibited remarkable activity against
nine type of cancer and also antiviral activity. Bozena et al. 37  have synthesized triazole
derivatives and tested for their anticonvulsant and antinociceptive activity. Sylvie Larrat
et al. 38  investigated that ribavarin in combination with alpha-2-interferon is the consensus
treatment for chronic hepatitis C. and E. De Clercq et al. 39  screened ribavarin (XII) for
their antiviral and antimetabolic activities.
(XIII)
    (XII)
NH
N
N
O
OH
OH
OH
CONH 2
NN
N
N
Oet
F
NH.SO 2
Cl
Cl
6. Plant growth regulator25
7. Anticancer and Anti-HIV26
8. Antileshmanial27
9. Antitumor28
10. Antidepressant and anxiolytic 29
11.  Anthelmintics30
12.  Antimicrobial31
13.  Antiviral32
14.  Antiinflammatory33
15.  Antihypertensive 34
16.  Anticonvulsant 35
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B. Shivarama Holla et al. 40  have investigated some triazole derivatives as anticancer
agents. Damien Boeglin et al.4 1  have suggested 3,4,5-trisubstituted 1,2,4-triazole
derivatives useful as an antimicrobial agents. Mckendry and co-workers4 2  have
synthesized triazole derivatives (XIII) and reported them as broad spectrum broadleaf
herbicides. L. Labanauskas et al. 43  have documented antiinflammatory activity of some
triazoles. Vera Klimesova et al. 44  have reported 1,2,4-triazoles useful for tuberculosis
inhibition.
Dickinson Roger P. and co-workers45  have prepared Voriconazole (XIV) and found
highly active against Aspergillus fumigatus  and a-(hetero-arylmethyl)-1H-1,2,4-triazole-
1-ethanol derivatives (XV) are active against Candida albicans and Cryptococous
neofermans .
    (XIV)   (XV)
Daniele Binchi et al.46  have screened pure stereoisomer of two new triazole
derivatives (XVI , XVII) for their antifungal activity against variety of fungi showing an
activity ratio R-form / S-form up to 400.
    (XVI)                                         (XVII)
N
N
N
Me
N N
F
F
F
OH
N
N
N
Me
N N
F
F
F
OH
Cl
Cl
OH
N
N
N
Cl
Cl
OCF 2CHF 2
N
N
N
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Recently, Krzysztof W. et al47  have discovered 1,2,4-triazole and reported their
antimycobacterial activity. Dae-Kee Kim et al. 48  have been synthesized 1,2,4-triazole
derivatives (XVIII) and screened for their significant ALKS inhibitory activity.
Fisher Karl J. et al. 49  have synthesized 1,2,4-triazole derivatives (XIX) to study their
pesticidal and herbicidal activity. Balkovee et al. 50  have formulated triazoles as
antidiabetic agent. Maarouf et al. 51  have documented analgesic and antiinflammatory
activity of 1,2,4-triazole derivatives.
(XVIII)  (XIX)
Thus the important role displayed by triazole moiety for various therapeutic and
medicinal activities promoted us to synthesize some thiadiazoles, thiadiazines,
thiadiazepines, aryl triazoles, sulphonamides, aryl amides and mannich bases bearing
triazole moiety, in order to achive compounds having better drug potential. This
study is described in the following parts.
 PART-I : SYNTHESIS,   CHARACTERIZATION     AND
BIOLOGICAL SCREENING OF THIADIAZOLES.
 PART-II : SYNTHESIS,  CHARACTERIZATION AND
BIOLOGICAL  SCREENING OF 4-ARYL TRIAZOLES.
 PART-III : SYNTHESIS, CHARACTERIZATION AND
BIOLOGICAL SCREENING OF THIADIAZINES.
N
N
N
N
R1
R3
R2
N
H
N
N
H
S
NH
Et
O
Cl
Cl
F3C
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   PART-IV : SYNTHESIS, CHARACTERIZATION AND
BIOLOGICAL SCREENING OF THIADIAZEPINES.
PART-V : SYNTHESIS,  CHARACTERIZATION AND
BIOLOGICAL  SCREENING OF SULPHONAMIDES.
PART-VI : SYNTHESIS, CHARACTERIZATION AND
BIOLOGICAL SCREENING OF ARYL AMIDES.
PART-VII : SYNTHESIS,  CHARACTERIZATION AND
BIOLOGICAL SCREENING OF MANNICH BASES.
PART-VIII : SYNTHESIS, CHARACTERIZATION AND
BIOLOGICAL SCREENING OF OXADIAZOLES.
1,2,4-Triazole...
34Studies on Medicinally...
      REACTION SCHEME
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PART - I
STUDIES ON
THIADIAZOLES
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INTRODUCTION
Thiadiazole derivatives have played an important role in pharmaceutical
industries and exhibited various biological activities due to the presence of –
N=C-S group.1 In thiadiazole ring system one sulphur and two nitrogen atoms are
present in a five membered ring. According to their position, thiadiazole systems
are classified as 1,2,3-thiadiazole (I), 1,2,4-thiadiazole (II), 1,3,4-thiadiazoles
(III) and 1,2,5-thiadiazoles(IV).
.
 (I) (II)       (III)     (IV)
Among these four types of thiadiazoles, 1,3,4-thiadiazole is well known. Fischer
has described the first 1,3,4-thiadiazole in 1882 and further developed by Buch and
co-workers.
SYNTHETIC ASPECT
Literature survey reveals that several publications and patents2 described
the synthesis of 1,3,4-thiadiazole as under.
1. Li-xue Zhang et al. 3 have synthesized 1,3,4-thiadiazoles by the cyclization of
aromatic acid with triazole in presence of POCl
3
.
2.   Jag Mohan et al. 4 have prepared thiadiazole derivatives by the cyclization of amino
mercapto triazole and aryl aldehyde in presence of p-Ts-OH.
 (VI)
     (V)
O
N
N
N
SHNH2
Ar-COOH
POCl 3 O
N
N
N
N S
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S
N
N
S
N
N
S
N N
S
N N
N
N
R
N
NH2
Ar-CHO
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N
N
N
H
S
R
R1
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3.        Microwave irradiation used for the preparation of thiadiazole using DMF as  an
 energy transfer medium was reported by Kidwai Mazaahir et al. 5
4.   Zhong-Yi et al. 6  have been prepared thiadiazole derivatives (VII) from
amino mercapto triazole and aryl aldehyde in presence of L-(+)-tartaric acid.
      (VII)
5.    Q.Bano and co-workers 7 have been prepared 6-phenyl amino-1,3,4-thiadiazole
(VIII) by reacting triazole with amino acid.
       (VIII)
6.   Alaa Hassan et al. 8 have prepared 1,3,4-thiadiazoles by the cyclization of
tetracyanoethene and 4-phenyl thiosemicarbazides.
    (IX)
N
N N
NH2
R SH
R-CHO
L- (t)- tartaric acid N
N N
R
NH
S
R
R O
N
N
N
NH2
SH
R
O
N
N
N
N S
NH
R
NH NH
NH2
S
+ S
N
N
RHN
N
N
N N
NN
7.    Khosrow Zamani et al. 9 have prepared thiadiazole from the thiosemicarbazide
by the cyclization in sulphuric acid.
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     (X)
BIOLOGICAL IMPORTANCE
Literature survey revealed that various thiadiazoles have resulted in many potential
drugs and are known to exhibit a broad spectrum of pharmacological properties. The
specific pharmacological activities associated are as under.
1. Antitumor10
2. Antiviral11
3. Antibacterial12
4. Amoebicidal13
5. Antagonist agent14
6. Antitubercular15
7. Antipyretic 16
8. Antinelmintic 17
9. CNS depressant 18
10. Antischistosomal19
11. Herbicidal20
12. Insecticidal21
13. Pesticidal22
14. Hypoglycemic23
N
NH
O
NH
NH
S
CH3
Con.H2SO4
N
N
N
S
NH
CH3
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Vergne, Fabrice et  al. 24  have synthesized 1,3,4-thiadiazole derivatives (XI) and
screened for their antiinflammatory, anticancer and anti-HIV activity. Laddi U.V. et
al. 25  have discovered thiadiazoles possessing antimicrobial and antituberculosis activity.
Gamill Ronald B. et al.26  have reported thiadiazoles as antiinflammatory agents.
Mobinikhaledi, A. et al. 27  have investigated 1,3,4-thiadiazoles and tested for insecticidal
activity. Che,Chao et al. 28  have prepared thiadiazole derivatives showed antifungal
and plant growth regulating effect.
(XI)
Celine Chazalete et  al. 29  have synthesized acetazolamide (XII) possessing
diuretics and antiglaucoma activity. Athansia Varvaresou et  al. 30  suggested thiadiazoles
and reported them as antidepressant. Pradeep Mishra et al. 31  have screened 1,3,4-
thiadiazoles for their potent spasmolytic activity and anti-inflammatory activity. Bernard
Masercel et al. 3 2  have synthesized 1,3,4-thiadiazoles possessing potent carbonic
anhydrase inhibitor properties and also prepared 5-valproyl amino 1,3,4-thiadiazole-2-
sulphonamide (XIII)  as strong anticonvulsant.
N
N
S
N
Me
SO2
NH2
Cl
S
N N
SO2NH2MeHNOC
CH3
CH3
NH
O
N
N
S
SO2NH2
       (XII) (XIII)
Claudiu T. Supuran and Andrea Scozzafava 33  have reported 1,3,4-thiadiazole
derivatives as carbonic anhydrase inhibitors and antitumor. Erhan Palaska et al. 3 4
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synthesized thiadiazoles containing anti-inflammatory activity. J. M. Colacino et al. 35
have documented anti-influenza virus  activity of thiadiazoles.
Lisa M. Thomasco et al. 36  have prepared 1,3,4-thiadiazole (XIV) possessing
potent antibacterial activity against Gram positive and Gram negative organisms.
Samir A. Carvalho and co-workers37  have documented antitrypanosomal profile of 1,3,4-
thiadiazole derivatives (XV). Zahra Kiani et al. 38  have discovered thiadiazoles as
antituberculosis agent.
S
N N
R
F
N
O
O
NH CH3
O
(XIV)
N
N
O2N
CH3
N
N
S
NH
N
OH
OH
(XV)
Alireza faroumadi et al. 39  have synthesized 1,3,4-thiadiazoles (XVI) and studied
their leishmanicidal activity. Hatice Dogan et al. 40  have prepared 2,5-disubstituted-1,3,4-
thiadiazolo derivatives as anticonvulsant and antimicrobial agent. Nalan Terzioglv and
Aysel Gursoy41  have discovered thiadiazoles and studied their anticancer activity. Alireza
Foroumadi and co-workers 42  have documented antituberculosis activity and cytotoxicity
of 1,3,4-thiadiazoles.
X= O,S
Y= CH2,O,NR
   (XVI)
X
O2N S
N N
N
y
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Recently S. Karakus and S. Rollas43  have screened thiadiazoles for their
antituberculosis activity. Jui-Yi Chou et al. 44  have synthesized thiadiazoles and reported
them as anticancer agents.
In light of wide verities of therapeutic activities exhibited by thiadiazole, we have
embarked upon the synthesis of some new thiadiazole derivatives which have been
described in following sections.
SECTION-I     : SYNTHESIS AND BIOLOGICAL SCREEINING OF 3-(m-
CHLOROPHENYL)-6-ARYL[1,2,4]TRIAZOLO[3,4-b]
[1,3,4]THIADIAZOLES.
SECTION-II    : SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-
CHLOROPHENYL)-6-ARYL-5,6-DIHYDRO[1,2,4]
TRIAZOLO[1,3,4]THIADIAZOLES.
Thiadiazoles...
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZOLES.
Thiadiazole derivatives are associated with broad spectrum of biological activities.
In view of these finding it appeared of interest to synthesize some newer thiadiazole
derivatives, with better potency. Thiadiazoles of type (I) have been prepared by
cyclocondensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with
different aromatic acids in presence of POCl3, as shown in reaction scheme.
     Type (I) R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.1.
N N
N
Cl
NH2
SH
N N
N
Cl
N
S
R
R-COOH
POCl 3
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ANTIMICROBIAL ACTIVITY
Method : Cup-plate45,46
Gram positive bacteria : Bacillus substillus
  Bacillus megaterium
Gram negative bacteria : Proteus vulgaris
  Escherichia coli
Fungi : Aspergillus niger
Concentration : 40 µg/ml
Solvent : Dimethyl formamide
Standard drugs : Ampicillin, Amoxycillin, Norfloxacin, Benzyl-
  penicillin, Greseofulvin
The antimicrobial activity was compared with standard drugs Viz.,
Ampicillin, Amoxycillin, Norfloxacin, Benzyl penicillin and antifungal activity was
compared with Greseofulvin. The zones of inhibition have been measured in mm.
Thiadiazoles...
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 Observed
Aromatic C-H  str. 3033 3080-3030 47
C=C str. 1507 1585-1480 47
C-H i.p. (def) 1145 1145-1090 47
1034 1070-1000 47
Triazole C=N str. 1602 1612-1593 47
C-N str. 1384 1380-1310 48
C-N-C str. 1145 1146-1132 47
N-N str. 1034 1050-1010 49
Ether C-O-C str.(asym.) 1258 1275-1200 48
(Ar-O-R) C-O-C str.(sym.) 1034 1075-1020 47
Halide C-Cl str. 758 800-600 47
Thiadizole C-S-C str. 693 720-570 47
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
METHOXYPHENYL)[1,2,4]TRIAZOLO[3,4-b] [1 ,3 ,4]THIADIZOLE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
0.0
20.0
40.0
60.0
80.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cm
 677.9
 693.4
 730.0
 785.9
 942.2
 957.6
 993.3
1034.7
1145.6
1258.5
1384.8
1436.9
1459.0
1507.3
1521.7
1539.1
1602.7
2327.0
3033.8
3457.2
3945.1
N N
N
Cl
N
S
OCH3
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NMR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
METHOXYPHENYL)[1 ,2 ,4 ]TRIAZOLO[3 ,4 -b] [ 1 , 3 , 4 ] T H I A D I Z O L E
1 3.92 3H singlet Ar-OCH3     -
2 7.06 2H doublet Ar-H(aa ') Jab=8.4
3 7.50 2H doublet Ar-H(ed) Jed=8.1
4 7.90 2H doublet Ar-H(bb ') Jba=8.7
5 8.34-8.31 1H double Ar-Hd Jde=5.7
doublet
6 8.43 1H singlet Ar-Hc     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
N
S
OCH3
d
e
f
c
b
b'
a
a'
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MASS SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
METHOXYPHENYL)[1 ,2 ,4 ]TRIAZOLO[3 ,4 -b] [ 1 , 3 , 4 ] T H I A D I Z O L E
Expanded aromatic region of NMR spectra
N N
N
Cl
N
S
OCH3
N N
N
Cl
N
S
OCH3
d
e
f
c
b
b'
a
a'
M/Z= 342
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EXPERIMENTAL
[A]      Preparation of  potassium-m-chlorobenzyl dithiocarbamate.
To a mixture of potassium hydroxide (8.40g, 0.15 mol) and 3-
chlorobenzohydrazide (17.0g, 0.1mol) in methanol (25ml), carbon disulphide (11.4g,
0.15mol) was added. This mixture was stirred for 12-14 hours. It was then diluted
with  dry ether (200 ml) and thus the solid obtained was filtered and washed with ether
and dried. There is no need to purify the salt for further reaction.
[B]      Preparation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol.
A  suspension of the potassium salt (24.5g, 0.1 mol), hydrazine hydrate (10 ml,
0.2 mol) and water (2 ml) was refluxed with stirring for 3 hours. The color of the reaction
mixture changed to green, hydrogen sulfide was evolved (lead acetate paper and odour)
and a homogeneous solution resulted. Dilute the solution with  of cold water (100 ml)and
neutralized with glacial acetic acid, precipitated a white solid. The product was filtered,
washed with cold water and crystallized from  dioxane yield 60%,  m.p. 190oC.
[C] Preparation of 3-(m-chlorophenyl)-6-(p-methoxyphenyl)[1,2,4]triazole
[3,4-b][1,3,4]thiadiazole
A mixture of p-methoxy benzoic acid (1.52g, 0.01 mol) and 4-amino-5-(m-
chlorophenyl)-4H-1,2,4-triazole-3-thiol (2.26g, 0.01 mol)in POCl3 (25 ml) was
refluxed for 10 hrs. The reaction mixture was poured onto crushed ice and thus
solid separated out was filtered, washed with water and crystallized from methanol.
Yield 64%, m.p. 210oC. Anal, Calcd. For C16H11ClN 4OS : C, 56.06 ; H, 3.23 ; N,
16.34 %; Found : C, 56.02 ; H, 3.20 ; N, 16.30%.
Similarly other thiadiazoles were prepared and the physical constants are
recorded in Table No. 1.
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZOLES.
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[D] Antimicrobial activity of  3-(m-chlorophenyl)-6-aryl-[1,2,4]triazole[3,4-
b][1,3,4]thiadiazoles
All the compounds have been evaluated for antimicrobial and antitubercular
activity as described under.
(a) Antimicrobial activity
It was carried out buy cup-plate diffusion method which has been described
as under.
(I) Antibacterial activity
The purified products were screened for their antimicrobial activity. The
nutrient agar broath prepared by the usual method, was inoculated aseptically with 0.5
ml of 24 hrs. old subcultures of B. coccous, B. subtillis, E. Coli, and P. vulgaris in
separate conical flasks at 40-50oC and mixed well by gentle shaking. About 25ml content
of the flask were poured and evenly spreaded in a petridish (13cm in diameter) and
allowed to set for 2 hrs. The cups (10 mm in diameter) were formed by the help of borer
in agar medium and filled with 0.04ml (40mg) solution of sample in DMF.
The plates were incubated at 37oC for 24 hrs. and the control was also maintained
with 0.04 mole of DMF in a similar manner and the zones of inhibition of bacterial growth
were measured in millimeter and are recorded in Graphical Chart No.1.
(II) Antifungal activity
A. niger was employed for testing antifungal activity using cup-plate method.
The culture was maintained on subouraud’s agar plants. Sterilized sabouraud’s agar
medium was inoculated with 72 hrs. old 0.5 ml suspension of fungal spores in a separate
flask.
About 25 ml of inoculated medium was evenly spreaded in a petridish and allowed
to set for two hrs. The plates were incubated at 30oC for 48 hrs. After the completion
of incubation period, the zone of inhibition of growth in the form of  diameter in mm was
measured. Along the test solution in each petridish one cup was filled with solvent which
act as control. The zones of inhibition are recorded in Graphical Chart No. 1.
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SECTION-II
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,3,4]THIADIAZOLES.
Thiadiazole derivatives are endowed with variety of biological activities. Looking
to the interesting properties of thiadiazoles, it was considered worthwhile to synthesize
a series of 3-(m-chlorophenyl)-6-aryl-5,6-dihydro[1,2,4]triazole[1,3,4]thiadiazoles of
type (II) for obtaining biologically potent agents. Thiadiazoles of type (II) have been
synthesized by cyclocondensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-
3-thiol with different aromatic aldehydes in presence of p-TsOH (p-toluene sulphonic
acid) as a catalyst, as shown under.
N
N
N
Cl
NH2
SH
+ R-CHO
N
N
N
N
H
S
Cl
R
p-Ts-OH
Type (II) R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro  biological assay
like antibacterial activity towards Gram positive and Gram negative bacterial strains
and antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml.
The biological activity of the synthesized compounds have been compared with
standard drugs. Some compounds have been found to have moderate activity as
compared to known antibiotics recorded on Graphical Chart No.2
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 Observed
Aromatic C-H  str. 3070 3080-3030 47
C=C str. 1535 1585-1480 47
C-H i.p. (def) 1080 1125-1090 47
1027 1070-1000 47
C-H o.o.p. (def) 832 835-810 47
Triazole C=N str. 1601 1612-1593 47
C-N str. 1166 1220-1020 50
N-N str. 1027 1050-1010 47
Ether C-O-C str.(asym.) 1252 1275-1200 48
(Ar-O-R) C-O-C str.(sym.) 1027 1075-1020 47
Halide C-Cl str. 774 800-600 50
Thiadizole N-H str. 3440 3450-3200 47
N-H def. 1569 1650-1580 47
C-S str. 700 720-570 48
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
M E H O X Y P H E N Y L ) - 5 , 6 - D I H Y D R O[ 1 , 2 , 4 ] T R I A Z O L O [ 3 , 4 -
b][1,3,4]THIADIAZOLE
 
0.0
20.0
40.0
60.0
80.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cm
 671.2
 700.1
 774.4
 798.5
 832.2
 960.0
 969.2
 983.6
1027.0
1080.0
1166.9
1215.1
1252.7
1290.3
1361.7
1408.9
1497.61510.2
1535.2
1569.0
1601.8
2760.9
2934.5
3070.0
3440.8
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
N N
N
Cl
N
H
S
OCH3
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NMR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6- (p-
M E H O X Y P H E N Y L ) - 5 , 6 - D I H Y D R O [ 1 , 2 , 4 ] T R I A Z O L O [ 3 , 4 -
b][1,3,4]THIADIAZOLE
1 3.89 3H singlet Ar-OCH3     -
2 7.01 2H doublet Ar-H(aa ’) Jab=8.7
3 7.44 2H doublet Ar-H(fg) Jfe=8.1
4 7.88 2H doublet Ar-H(bb ’) Jba=8.7
5 7.90 1H doublet Ar-He Jef=7.5
6 8.01 1H singlet Ar-Hd     -
7 9.85 1H singlet Ar-Hc     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
N
H
S
OCH3a
a'
b
b'c
de
f
g
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MASS SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6- (p-
M E H O X Y P H E N Y L ) - 5 , 6 - D I H Y D R O [ 1 , 2 , 4 ] T R I A Z O L O [ 3 , 4 -
b][1,3,4]THIADIAZOLE
Expanded aromatic region of NMR spectra
N N
N
Cl
N
H
S
OCH3
N N
N
Cl
N
H
S
OCH3a
a'
b
b'c
de
f
g
M/Z= 344
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,3,4]THIADIAZOLES.
[A]      Preparation of  potassium-m-chlorobenzyl dithiocarbamate.
See Part-I, Section-I [A]
[B]      Preparation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol.
See Part-II, Section-I [B]
[C]     Preparation of 3-(m-chlorophenyl)-6-(p-methoxyphenyl)-5,6-
           dihydro[1,2,4]triazole[1,3,4]thiadiazole
A mixture of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol (2.26g,
0.01mol), p-anisaldehyde (1.39g, 0.01 mol) and p-Ts-OH (50 mg) in dry DMF (50
ml) was refluxed with stirring for 10 hrs. The reaction mixture was poured on to crushed
ice and thus solid separated was filtered, washed with water and crystallized from
methanol yield 60%, m.p. 265oC, Anal. Calcd. For C 16H13ClN 4OS: C, 55.73; H, 3.80;
N, 16.25 %; Found: C, 55.70; H, 3.76; N, 16.21 %.
Similarly other aromatic aldehyde have been condensed. The physical
constants are recorded in Table No.2.
[D] Antimicrobial activity of 3-(m-chlorophenyl)-6-aryl-5,6-
dihydro[1,2,4]triazole[1,3,4]thiadiazoles
Antimicrobial testing was carried out as described in Part-(I), Section-I (D).
The zones of inhibition of the test solution are recorded in Graphical Chart No.2.
Thiadiazoles...
60Studies on Medicinally...
2a
4-
O
C
H
3-
C
6H
4-
C
16
H
13
C
lN
4O
S
34
4
26
5
60
16
.2
5
16
.2
1
0.
52
S2
2b
3,
4-
(O
C
H
3)
2-
C
6H
3-
C
17
H
15
C
lN
4O
2S
37
4
19
5
58
14
.9
5
14
.9
3
0.
57
S2
2c
3-
N
O
2-
C
6H
4-
C
15
H
10
C
lN
5O
2S
35
9
23
0
69
19
.4
7
19
.4
4
0.
47
S1
2d
2-
N
O
2-
C
6H
4-
C
15
H
10
C
lN
5O
2S
35
9
21
0
58
19
.4
7
19
.4
4
0.
42
S2
2e
4-
O
H
-C
6H
4-
C
15
H
11
C
lN
4O
S
33
0
18
0
47
16
.9
4
16
.9
0
0.
57
S2
2f
-C
6H
5-
C
15
H
11
C
lN
4S
31
4
18
1
61
17
.8
0
17
.7
9
0.
52
S1
2g
3-
C
l-
C
6H
4-
C
15
H
10
C
l 2
N
4S
34
9
19
5
59
16
.0
4
16
.0
0
0.
48
S2
2h
4-
-C
H
3-
C
6H
4-
C
16
H
13
C
lN
4S
32
8
22
1
58
17
.0
4
17
.0
1
0.
52
S1
2i
4-
F-
C
6H
4-
C
15
H
10
C
lF
N
4S
33
2
18
9
50
16
.8
4
16
.8
1
0.
51
S1
2j
3-
C
l-
C
6H
4-
C
15
H
10
C
l 2
N
4S
34
9
17
8
64
16
.0
4
16
.0
0
0.
49
S2
2k
2-
O
H
-C
6H
4-
C
15
H
11
C
lN
4O
S
33
0
19
8
53
16
.9
4
16
.9
2
0.
47
S2
2l
3-
O
C
6H
5-
C
6H
4-
C
21
H
15
C
lN
4O
S
40
6
23
1
49
13
.7
0
13
.6
9
0.
48
S1
T
A
B
L
E
-2
 :
P
H
Y
SI
C
A
L
 C
O
N
ST
A
N
T
S 
O
F 
3-
(m
-C
H
L
O
R
O
P
H
E
N
Y
L
)-
6-
A
R
Y
L
-5
,6
-D
IH
Y
D
R
O
[1
,2
,4
]T
R
IA
Z
O
L
O
[3
,4
-b
]
[1
,3
,4
]T
H
IA
D
IA
Z
O
L
E
S
S1
 H
ex
an
e:
Et
hy
l a
ce
ta
te
(5
:5
), 
  S
2 
H
ex
an
e:
Et
hy
l a
ce
ta
te
(6
:4
)
Sr
.
N
o. 1
R 2
M
ol
ec
ul
ar
 F
or
m
ul
a
   
  3
M
ol
ec
ul
ar
  W
ei
gh
t
   
   
4
M
.P
.
O
C   5
Y
ie
ld
  %    
 6
%
 o
f N
it
ro
ge
n
C
al
cd
.
7
Fo
un
d
8
  R
f
V
al
ue
   
 9
So
lv
en
t
Sy
st
em
10
Thiadiazoles...
61Studies on Medicinally...
G
ra
ph
ic
al
 C
ha
rt
 N
o.
 2
 :
A
nt
im
ic
ro
bi
al
 A
ct
iv
it
y 
of
 3
-(
m
-c
hl
or
op
he
ny
l)
-6
-a
ry
l-
5,
6-
di
hy
dr
o
[1
,2
,4
]t
ri
az
ol
o[
3,
4-
b]
[1
,3
,4
]t
hi
ad
ia
zo
le
s
Thiadiazoles...
62Studies on Medicinally...
REFERENCES
1. Holla B.S., Poorjary N.K., Rao S.B., Shivananda M.K. ;
Eur. J. Med. Chem.,  37,  511 (2002).
2. Howard Sard, Peter C. Meltzer and Raj K. Razdan ;
J. Heterocycl. Chem. , 22,361 (1985).
3. Li-Xue Zhang, An-Jiang Zhang, Xian-Xan Chem, Xin-Xiang Lei,
Xiang-Yung Nan., et al.;
Molecules,  7, 681-689 (2002).
4. Jag Mohan, Anupama, Anju Rathee. ;
Indian J. Heterocycl. Chem.,  10,  01-04 (2000).
5. Kidwai Mazaahir, Kumar rajesh, Srivastava Anil, Gupta H.P. ;
Bio. Org. Chem., 26(5),  289-294 (1998) ; Chem. Abstr.,  131, 237538x
      (1990).
6. Wang, Zhong- Yi, You, Tian-pa, You, Ling-Feng. ;
Youji Huaxue,  19(3),  288-92 (1999) ; Chem. Abstr.,131, 199657w
(1999).
7. Q. Bano, N Tiwari, S Giri and Nizammuddin. ;
Indian J. Chem., 32B, 399-403 (1993).
8. Alla A. Hassan, Nasr K. Mohamed, Ahmed M. Shawky and Dietrich
Dopp;
ARKIVOC, 118-128(i) (2003).
9. Khosrow Zamani, Khaht Faghini, M. Reza Sangi and Javed
Zolghrenin. ;
Turk J. Chem.,  27, 119-125 (2003).
10. Mahram Mond A., El-Sherbeny Magda, El-Obaid Abdul-Rahman
M.A.; Badria Farid A. ;
Alexandria J. Pharm. Sci.,12(1),39-44 (1998);
Chem.Abstr.,129 ,67756b (1998).
11. F. Malinoski and V. Stoller ;
Virology,  110, 281(1981) ; Chem. Abstr. ,94,  186145v (1981).
12. Shi Hai-Jian, Shihao-Xin, Wang-Zhong Yi, Youji Huazue, 19(2), 119-
199 (1999).
Chem.Abstr.,131, 447161k (1999).
Thiadiazoles...
63Studies on Medicinally...
13. J. Bourdais, D. Dauvillier, P. Gayral, M.C. Rigo Heir, T. Julien, M.
Gasquest,T. C. Jamoulle, C.L.Lapiere. ;
Eur. J.Med.Chem.,  16, 233 (1981).
14. Allan Robin D., Apsotopoulos Christine, Richarson Jennider A. ;
Aust. J. Chem.,  43(10),  1767-72 (1990).
15. Kidwai Mazaahir, Kumar Rajesh, Shrivastava Anil, Gupta H. D. ;
Bio.Org.Chem.,  26(5),  289-294 (1998) ; Chem.Abstr., 131, 237538x
(1999).
16. Schenone Silvia, Bruno Olga, Ranise Angelo, Bondvalli Francesco. ;
Farmaco, 53,  (8-9), 586-589 (1998) ; Chem.Abstr., 130, 296650q
(1999).
17. Lee Byung H., Dutton Fred E., Clotheir Michael F., Bowman Jerry.;
Bio.Org.Med.Chem. Lett.,  9(12),  1727-1732 (1999).
18. M.R.Mody, A.R.Prasad, T.Ramlingam and P.B.Sattur. ;
Ibid.,  59,  769 (1982) ; Chem.Abstr., 97,2161310 (1982).
19. Omar Mohmoud T. ;
Egypt J. Pharm. Sci.,  1997 (Pub 1998), 38 (4-6),  271-280 (1997) ;
     Chem.Abstr. ,131, 257474x (1999).
21. K.Hoggarth, Paul Rathgab. ;
J. Indian Chem. Soc.,  52,  750 (1975); Chem.Abstr. 72, 127345 (1969).
22. C. Tony. ;
Gen. Offen.,  2, 050, 479 (1971) ; J.Indian.Chem.Soc.,  52,  750, (1975).
23. Huebl Dieter, Pierob Ernst Albrecht, Jappien H., Baument D. ;
Ger. Chem. D.E., 3, 821, 953 (Cl. CO7D285/72); Chem.Abstr.,
113,6350n (1990).
24. Galad A.K., Khaji I. M. Mahajan Shetti C.S. ;
Indian J. Heterocycl.Chem. 2(1), 207-56 (1992).
24. Vergne Febrice, Andrianjard Charles, Ducrot Pierre. ;
Eur. Pat. Appl. EP 1,  193,261 (Cl. CO7D285/135) (2002);
Chem.Abstr.,136(18), 279460v, (2002).
25. Laddi U.V., Talawar M.B., Desai S.R., Bennur R.S., Bennur S.C. ;
Indian J. Chem. Section B : Organic Chemistry including Medicinal
Chemistry,  40 B (9),  828-833 (2001); Chem.Abstr. 136(5),  69794f
(2002).
Thiadiazoles...
64Studies on Medicinally...
26. Gamill Ronald B., Vander Velde Susan, Nugent Richard Allen. ;
PCT Int. Appl. WO  99, 20,  618 (Cl.CO7D285/135) (1999).
Chem.Abstr.,130(23), 311799z (1999).
27. Mobinikhaledi A.; Zamani Kh; Iqbal R., Tofight T. ;
J.of the Chemical Society of Pakistan,  24(4), 269-274 (2002).
28. Che Chao, Mao Shu-Fen, Quin Zhao-Hai; Yingyong Hua-Xue. ;
Chem.Abstr.  137(23), 3378162 (2003).
29. Celin Chazalette, Bernard Masereel, Stephanie Rolin, Anne Thiry,
Andrea Scozzafava; et al.;
Bioorg. Med. Chem. Lett.,  14,  5781-5786 (2004).
30. Athansia Varvaresou, Theodora Siatrapapastailkoudi, Andrew Tsotinis,
Anna Tsantili-Kakoulidene, Alexandre Vamvakides. ;
IL Farmaco,  53(5),  320-326, (1998).
31. Pradeep Mishra, Shakva A.K. Agrawal R.K., Patniak G.K. ;
Short Communication, 22(2),  113-116, (1990).
32. Bernard Masercel, Stephanie Robin, Francesco Abbate, Andrea
Scozzafava, Claundiu T. Supuran.;
J.Med.Chem., 45,  312-320, (2002).
33. Claudiu T. Supuran, Andred Scozzafava. ;
Eur.J.Med.Chem., 35(9), 867-874 (2000).
34. Erhan Palaska, Gulay Sahin, Pelm Kelrcen N., Tugba Durla, Gulcan
Altinok.;
IL Farmaco,  57(2), 101-107 (2002).
35. J.M. Colacino, D.C.Delong, J.R.Nelson, W.A.Spitzer, J.Tang, F.Victar,
C.Y.Wu. ;
Antimicrob. Agents Chemother,  34(11), 2156-2163 (1990).
36. Lisa M. Thomasco, Robert C. Gadwood, Elizabeth A. Weaver, Jason
M. Ochoada, Charles W. Ford. et al. ;
Biorg. Med. Chem. Lett. 13(23),  4193-4196 (2003).
37. Samir A. Carvalho, Edson F. da Silva, Richardo M. Santa-Rita,
Solange L.de Castro, Carlos A.M. Fragd ;
Bioorg. Med. Chem.Lett., 14(24),  5976-5970 (2004).
38. Zahra Kiani, Fatemeh Sottani, Alireza Foroumadi. ;
IL Farmaco,  58(11), 1073-1076, (2003).
Thiadiazoles...
65Studies on Medicinally...
39. Alireza Foroumadi, Shirin Pournourmmadi, Fatemch Soltani, Mitra
Asgharian-Rezaee, et al. ;
Bioorg. Med. Chem. Lett. 15(8),  1983-1985 (2005).
40. Hatice N. Dogan, Arzu Duran, Sevim Rollas, Goksel Sener, Meral K.
Uysal and Dumrul Gulen. ;
Bioorg. andMed. Chem.,  10(9),  2893-2898, (2002).
41. Nalan Terzioglu, Aysel Gursoy. ;
Eur. J. Med. Chem., 38(7-8), 781-786, (2003).
42. Alireza Foroumadi, Ali Asadipour, Maryam Mirzaci, Javad Karimi,
Saeed Emami. ;
IL Farmaco,  57(9),  765-769, (2002).
43. S. Karakus and S. Rollas. ;
IL Farmaco,  57(7),  577-581, (2002).
44. Jui-Yi Chou, Shin-Yu Lai, Shiow-Lin Pan, Gucy-Mei Jow, Ji-Wang
Chern, Jih-Hwa Guh. ;
Biochemical Pharmacology,  66(1), 115-124, (2003).
45. A.L. Berry. ;
The antimicrobial Susceptibility test, Principle and Practice, illusled
and Febiger, Philadelphia,  180-93 (1976).
46. F. Simoncina, R.Rangane and C. Calani. ;
Farmaco Ed. Part, 23(10),  559-70 (1968). Chem.Abstr., 69,  019851d
      (1968).
47. V. M. Parikh;
“Absorption spectroscopy of organic molecule”.  Addition Wesley Pub.
  Co. London, 243-256 (1978).
     48. C. N. R. Rao;
“Chemical application of Infrared spectroscopy” Academic press,
New York (1963).
     49.  “Strukturaufklarang Organischer Verbindungen”
Mit Spektroskopischem methoden zweite, uberarbeiete and erganzte
  Auflage   (Springer -verlag, Berlin Beidel -berg, New York- 1981).
     50.  Silverstein Bassler and Morrill.;
           Spectroscopic identification of organic compounds  fifth edition
(1991) by John Wiley & Sons Inc.
Thiadiazoles...
66Studies on Medicinally...
    PART - II
STUDIES ON
4- ARYLTRIAZOLES
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INTRODUCTION
1,2,4-Triazoles have proved to be most useful framework for biological  activi-
ties among nitrogen containing five membered heterocycles. In five membered heterocy-
clic ring system 4-aryl triazole (I) have three nitrogen atoms at 1,2 and 4 positions, an
aryl group at 4-position and free mercapto group at 3-position.
      (I)  R=Aryl
SYNTHETIC ASPECT
Several methods have been reported in the literature for the preparation of 4-
aryltriazoles.
1. Alan R. Katritzky et al. 1  have synthesized 4-aryltriazoles by the cyclization of
semicarbazide.
        (II)
2. Khosrow Zamani et al. 2 synthesized 4-aryltriazole from thiosemicarbazide by ring
closure reaction with 2N NaOH.
        (III)
N
N N
SHX
R
1 2
3
4
5
O
NH
N NH
CH3
RCH3
N
N N
CH3 R2
R1
N
N N
SH
CH3
N
2N NaOH
N
NH
NH
O
S
NH
CH3
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BIOLOGICAL IMPORTANCE
4-Aryltriazoles are reported to exhibit a wide variety of biological
activities  such as,
1.  Antiinflammatory3
2. Biocides4
3.  Cholesteryl ester transfer protein5
4.  Antidepressant 6
Chang et al.7 have synthesized aryltriazoles (IV)  and reported them as antifungal
drugs. Crisan O. et al. 8 have screened antiinflammatory activity of triazoles. Varvaresou
A. et al.9 have synthesized triazoles and reported their antimicrobial potency and
antidepressant activities. Papakonstantinou et  al.1 0  have investigated some triazole
derivatives possessing significant antiviral activity. Konosu T. and co-workers11  have
prepared aryltriazoles as fungicides.
N
N N
Me
N
NH
N
SAr     (IV)
Yasuda N. et al.12  have discovered aryltriazoles which have been extensively
investigated for their antibacterial properties. S.C. Bahel et al. 13  have documented anti-
fungal activity of aryl triazoles. Athansia varvaresou et al. 14  have synthesized aryltriazoles
possessing antidepressant activity. Chu. Changhu et al. 15  have screened 4-aryltriazoles
(V) for their antifungal activity.
N
N
N
N
N
N
S
Ar
CH 2COOH
(V)
4-Aryltriazoles...
69Studies on Medicinally...
Some aryltriazoles possessing analgesic and diuretic activities have been
synthesized by Shrivastava S.K. et al. 16  Wang Sheng et al. 17  have reported triazoles as
herbicidal agents.
 Lowe R.F. and co-workers 18  have reported aryltriazoles  as useful antagonists.
Holla B. et al. 19  have documented anticancer activity of aryltriazoles. Welsh et al. 20  have
discovered aryltriazoles (VI) and reported them as analgesic agents.
N
N N
MeO
t-Bu
(VI)
Looking to this significant biological activity of 4-aryltriazole derivatives, it was
subject of interest to study some 4-aryltriazole derivatives which have been described
as under.
SECTION-I    : SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-
CHLOROPHENYL)-4-ARYL-4H-1,2,4-TRIAZOLE-3-
THIOLS.
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
4-ARYL-4H-1,2,4- TRIAZOLE-3-THIOLS.
4-Aryltriazole derivatives are associated with broad spectrum of pharmacological
activity. In views of these findings, it appeared of interest to synthesize 5-(m-
chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols. The synthesis of triazole derivatives
of type(III) have been undertaken by heating dry potassium-m-chloro benzyl
dithiocarbamate with different aromatic amines.
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro  biological assay
like antibacterial activity towards Gram positive and Gram negative bacterial strains
and antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml.
The biological activity of the synthesized compounds have been compared with
standard drugs. Some compounds have been found to have moderate activity as
compared to known antibiotics recorded on Graphical Chart No.3.
NH
NH
Cl
S
S
-
O
K
+
R-NH2
N N
N
Cl
R
SH
   Type (III) R=Aryl
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 Observed
Alkane C-H str. (asym.) 2960 2975-2950 21
  -CH3 C-H str. (sym.) 2850 2880-2860 21
C-H def.(asym.) 1435 1470-1435 21
C-H def.(sym.) 1375 1385-1370 21
Aromatic C-H  str. 3030 3080-3030 22
C=C str. 1558 1585-1570 22
1459 1520-1480 22
C-H i.p. (def) 1105 1125-1090 22
C-H o.o.p. (def) 815 835-810 22
Triazole S-H str. 2370 2400-2300 23
C=N str. 1630 1640-1500 21
C-N str. 1200 1220-1020 21
N-N str. 1026 1050-1010 23
C-S str. 667 700-600 23
Halide C-Cl str. 758 800-750 23
Type     Ref.
        Reported
Frequency in cm-1 Vibration
IR SPECTRAL STUDIES OF 5-( m-CHLOROPHENYL)-4-( p-
METHYLPHENYL)-4H- [1,2,4]TRIAZOLE-3-THIOL
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
0.0
20.0
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60.0
80.0
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%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cm
 610.0
 677.9
 750.3
 885.3
 993.3
1026.1
1105.0
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NMR SPECTRAL STUDIES OF 5-( m-CHLOROPHENYL)-4-( p-
METHYLPHENYL)-4H- [1,2,4]TRIAZOLE-3-THIOL
1 2.42 3H singlet Ar-CH3     -
2 7.38-7.53 4H multiplet Ar-(Haa ’+Hef)     -
3 7.79 2H doublet Ar-Hbb ’     -
4 7.90 2H doublet Ar-Hde     -
5 8.63 1H broad -SH     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
SH
CH3
d
e
f
c
a
a'
b
b'
g
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Expanded aromatic region of NMR spectra
N N
N
Cl
SH
CH3
MASS SPECTRAL STUDIES OF 5-( m-CHLOROPHENYL)-4-( p-
METHYLPHENYL)-4H- [1,2,4]TRIAZOLE-3-THIOL
N N
N
Cl
SH
CH3
d
e
f
c
a
a'
b
b'
g
M/Z= 301
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EXEPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
4-ARYL-4H-1,2,4- TRIAZOLE-3-THIOLS.
[A]      Preparation of  potassium-m-chlorobenzyl dithiocarbamate.
          See Part-I, Section-I (A)
[B]      Preparation of 5-(m-chlorophenyl)-4-(p-methyl phenyl)-4H-1,2,4-triazole-
          3-thiols.
A mixture of potassium-m-chlorobenzyl dithiocarbamate (2.85g, 0.01M) and p-
toludine (1.07g, 0.01M) was heated at 140 oC until the evolution of H2S gas ceased (10
hrs.). The product was dissolved in DMF (20ml), treated with dilute HCl and then poured
on to crushed ice. The product was crystallized from ethanol. Yield 70%, m.p. 220oC. Anal:
calcd. For C15H 12ClN 3S: C,59.70; H,4.01; N,13.92 %; Found ; C,59.66; H,3.96;
N,13.90 %.
Similarly other aromatic amines were condensed. The physical constants are
recorded in Table No.3.
[C]     Antimicrobial activity of 5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-
         thiols.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical chart No.3.
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    PART - III
STUDIES ON
THIADIAZINES
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INTRODUCTION
Thiadiazine is a six membered heterocyclic ring system having two nitrogen
atoms and one sulphur atom. These may be of four types 2H-1,2,4-Thiadiazine (I);
2H-1,2,6-Thiadiazine (II); 2H-1,3,4-Thiadiazine (III) and 2H-1,3,5-Thiadiazine (IV).
     
 (I)                (II)               (III)              (IV)
1,3,4-Thiadiazine derivatives are studied extensively because it represents one
of the most active class of compounds possessing a wide spectrum of pharmacological
activities.1-3 Many 1,3,4-thiadiazine derivatives involve in many biological processes and
serves as a medicinally interesting compounds.
SYNTHETIC ASPECT
Different methods for the preparation of 1,3,4-thidiazine derivatives described
in literature are as follows.
1. Heravi M.M. et al. 4 have reported that the cyclization of 4-amino-3-mercapto-
6-methyl-[1,2,4]triazine-5-one with phenacyl bromide gives 1,3,4-thiadiazine
derivatives (V).
NH
S
N
NH
S
N
N
S
N
N
S
N
N
N
N
NH2
OHS
Me
+ PhCOCH 2Br N
N
N
N
S
Ph
Me
O
 (V)
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2. Bayoumy B.E. El-Feky S.A. et al. 5 have designed thiadiazine ring system (VI)
 by the reaction of phthalazinone triazole with phenacyl bromide.
N
N
N
N
N
O NH2
SH
CH2Ph
+ R'COCH 2Br
N
N
N
N
N
O
CH2Ph
N
S
R'
(VI)
R’=Ph, 4-Br-C
6
H
4
O
O2N
HC
CH
Br
Br
O
R
+ N
N N
SHR'
NH2
Et3N
Dioxane
N
N N
N
S
R
O
NO2
R'
3. B.Shivarama Holla et al. 6 have synthesized triazole thiadiazines (VII) by the
cyclization of 2,3-dibromo-1-aryl-3-[5-(p-nitrophenyl)-2-furyl]-2-propen-1-
ones and substituted 1,2,4-triazole.
(VII)
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4. Campaigne  E.   and   Selby   T. P. 7 have  prepared 1,3,4-thiadiazine by the
condensation of ethyl-4-chloroacetoacetate with thiosemicarbazide.
5. Alberecht   William   L.  et  al. 8   have  synthesized  s-triazolocycloalkyl
hydrothiadiazines  (VIII) by  the  cyclization  of a-haloketones  with  5-
substituted-4-amino-4H-1,2,4-triazole-3-thiols.
   (VIII)
6. Ahmad S. Shawali et al. 9 have synthesized triazolothiadiazines (IX) by the
cyclization of 4-amino-3-mercapto-5-phenyl-1,2,4-triazole and 3-chloro-2,4-
pentaanedione.
(CH2)n Br
O
+
N
NH
N
SH
NH2 Et
(CH2)n
N
S
N
N
N
Et
N
N N
H
SPh
NH2
+ ClCH(COCH 3)2
N
H
N
N
S
NPh
CH3
COCH 3
H
 (IX)
BIOLOGICAL IMPORTANCE
Literature survey reveals that various 1,3,4-thiadiazines have resulted in many
potential drugs and are known to exhibit a broad spectrum of biological activities.
1,3,4-Thiadiazine derivatives possess wide range of therapeutic activities which
are as under.
1. Antifungal1 0
2. Antibacterial1 1
3. Antimicrobial1 2
4. Antiinflammatory1 3
5. Cardiovascular14-15
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6. Analgesic 16
7. Antidepressant 17
Renuka Devi Patil and J.S. Biradar18  have reported triazolothiadiazine derivatives
as anthelmintic, antiinflammatory and anticatatonic active agents (X). Turan-Zitouni G.
et al. 19  have demonstrated analgesic activity of triazole thiadiazines (XI).
N
H
N
N
N
N
S
Ph
Ph
OCH2
N
N
N
N
S
R1
R2
(X)                                                     (XI)
R
1
= H      R
2
= Cl,NO
2
R
1
= OH    R
2
= OCH
3
Mazzone G. et al. 2 0 - 2 1  reported 1,3,4-thiadiazine derivatives as weak
antiinflammatory agent and also reported their analgesic activity. Jonas Rochus et al. 22-23
have prepared new thiadiazine derivatives useful as phosphodiesterase IV inhibitors (XII)
and cardiovascular agents (XIII).
(XII) (XIII)
Z= bond OR alkylene R1,R2 = H OR Halo
R5= Substituted Phenyl R3,R4 = OH, alkoxy, halo
NH
SZN
R4
R3
R2
R1
R2
O
R5 
S
N N
N
O
OMe
OMe
Me
O
R
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O
N
N
S
N
N
O
R
(XIV)        (XV)
N
N N
N
S
OEt
O
R
Nadkarni B.A. et al. 28 have reported anthelmintic activity of 1,3,4-thiadiazines.
El-Shorbagi A N. et al. 29  documented antimicrobial activity of thiadiazine derivatives.
Holla B.S. et al. 30  have also reported antibacterial and anticancer activity of 1,3,4-
thiadiazines. Vicentini C.B. et al. 31  have documented thiadiazines as fungicides.
The diverse biological activities have been encountered in compounds containing
triazolothiadiazine ring system. Therefore it was considered worthwhile to synthesize
1,3,4-thiadiazine derivatives which have been described as under.
SECTION-I       : SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-
CHLOROPHENYL)-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-
b][1,3,4]THIADIAZINES.
Aboul-Fadi T. et al. 24  reported antituberculous activity of thiadiazines. Pirotte B.
et al. 25  have documented thiadiazine derivatives as ATP channel openers. Kalluraya B.
et al. 26-27 have reported 3-substituted-7H-6-(6-bromo-3-coumarinyl)-s-triazolo [3,4,b]
[1,3,4] thiadiazines and subjected to antibacterial activity (XIV). Lee, An Rong Taiwan
have been reported and pentented triazolothiadiazines as antiinflammatory agents (XV).
Thiadiazines...
85Studies on Medicinally...
SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES.
Thiadiazine derivatives represent on of the most active class of compounds having
a wide spectrum of biological activities. With an aim to getting better therapeutic agent,
the preparation of 1,3,4-thiadiazine of type (IV) have been undertaken by the
condensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different
substituted phenacyl bromides.
N N
N
Cl
SH
NH2
R-COCH 2Br
N N
N
N
S
Cl
R
Type - (IV) R = Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.4.
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 Observed
Aromatic C-H  str. 3057 3080-3030 35
C=C str. 1571 1585-1480 35
C-H i.p. (def) 1123 1125-1000 36
C-H o.o.p. (def) 829 835-810 36
Triazole C=N str. 1636 1650-1580 37
C-N str. 1036 1050-1010 35
N-N str. 1123 1220-1020 36
Ether C-O-C str.(asym.) 1229 1275-1200 36
(Ar-O-R) C-O-C str.(sym.) 1036 1075-1020 35
Halide C-Cl str. 757 800-600 35
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
METHOXYPHENYL)-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
0.0
20.0
40.0
60.0
80.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cm
 465.8
 637.4
 658.6
 685.6
 731.0
 757.0
 829.3
 919.0
 999.1
1036.7
1123.4
1229.5
1366.5
1469.7
1571.9
1597.9
1633.6
2898.8
3057.0 N N
N
Cl
N
S
OCH3
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NMR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
METHOXYPHENYL)-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINE
1 3.98 3H singlet Ar-OCH3     -
2 4.22 2H singlet Ar-Hc     -
3 7.11 2H doublet Ar-Haa ’     -
4 7.43-7.50 4H multiplet Ar-(Hbb ’+Hfg)     -
5 7.94-8.05 2H multiplet Ar-Hed     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
N
S
OCH3
e
f
g
d
c
a
a'
b
b'
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MASS SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-6-( p-
M ETHOXYPHENYL)-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINE
Expanded aromatic region of NMR spectra
N N
N
Cl
N
S
OCH3
N N
N
Cl
N
S
OCH 3
e
f
g
d
c
a
a'
b
b'
M/Z= 357
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES.
[A] Preparation of potassium-m-chlorobenzyl dithiocarbamate.
See Part-I, Section-I (A).
[B] Preparation of 5-(m-chlorophenyl)-4-aryl-4H-12,4-triazole-3-
thiols.
See Part-I, Section-I (B).
[C] Preparation of  p-methoxyphenacyl bromide.
To a well stirred solution of p-methoxy acetophenone (1.50g, 0.01mol)
in  glacial acetic acid (20 ml) and  hydrochloric acid (0.11 ml) at ambient temperature,
bromine (0.8g, 0.01mol) in glacial acetic acid (10 ml) was added over a period of 1hr.
The reaction mixture was diluted with  water (500 ml) and extracted with chloroform.
The combined extracts were dried (over MgSO4) and concentrated to give 4-methoxy
phenacyl bromide.
Similarly other substituted phenacyl bromides were prepared by using literature
methods.32-34
[D] Preparation of 3-(m-chlorophenyl)-6-(p-methoxyphenyl)-7H-[1,24]
triazolo[3,4-b][1,3,4]thiadiazine.
A mixture of 5-(m-chlorophenyl)-4-aryl-4H-12,4-triazole-3-thiol (2.26g,
0.01 mol) and p-methoxyphenacyl bromide (2.28g,0.01mol) in dry methanol (50ml) was
heated under reflux for 5 hrs. The content was cooled and neutralized with aqueous
potassium carbonate solution. The solid thus separated was filtered, washed with water
and recrystallized from ethanol. Yield 60%, m.p. 210oC. Anal.Calcd. For C 17H13ClN 4OS:
C,57.22; H,3.63; N,15.70 %; Found: C,57.18; H,3.60; N,15.66 %.
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Similarly other phenacyl bromides have been condensed. The physical
constants are recorded in Table No.4.
[E]        Antimicrobial activity of 3-(m-chlorophenyl)-6-aryl-7H- [1,2,4]triazole
            [3,4-b]thiadiazines.
Antimicrobial testing was carried out as described in part-(I), section-I
(D). The zones of inhibition of compounds are recorded in Graphical Chart No.4.
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    PART - IV
STUDIES ON
THIADIAZEPINES
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INTRODUCTION
In seven membered ring system, the presence of two nitrogen and one sulphur
hetero atoms defines an interesting class of compounds, the thiadiazepines. 1,3,4-
thiadiazepine derivatives are studied extensively because it represents one of the
most active class of compounds possessing a wide spectrum of pharmacological
activities. Keeping in association of thiadiazepine with varied activity, we have
been studied 1,3,4-thiadiazepine (I).
      
(I)
1,3,4-Thiadiazepine derivatives have been found to be potent drug in
pharmaceutical industries.
SYNTHETIC ASPECT
Different methods for the synthesis of thiadiazepine derivatives have been
described in literature.1-3
1.     1,2,4-Triazolo [3,4-b][1,3,4] thiadiazepine (II) have synthesized by Tiwari
         Nirupama et al. 4 by cyclocondensation of 4-amino-5-mercapto-1,2,4-triazoles
        with 2,4-pentanedione.
N
N
S
1
2
3
4 5
6
7
R
N
N
N
NH2
SH
+
CH3 CH3
O O
R
N
N
N
S
N
CH3
CH3(II)
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2.      Brukstus A. 5 have been synthesized benzimidazo [2,1-b] pyrimido [5,4-f][1,34]
       thiadiazepine (III).
  (III)
3.      Cyclization of ClCH2CH2COOH with PhNHNHCSNH2 in presence of AcOH
         containing NaOH at  reflux  temperature  to  give  2-amino-4-phenyl-6H, 7H-
        1,3,4-thiadiazepin-5-one 6(IV).
(IV)
4.      Om Prakash et al. 7 have synthesized thiadiazepine by Michael type addition
          of 4-amino-3-mercapto-1,2,4-triazole to a,a-unsaturated carbonyl compounds.
N
N
CHO
Cl
ClMeS
+
N
H
N
NH2
S
N
N
N
S
N
Cl
MeS
PhHNHN NH2
S
+ ClCH 2CH 2COOH
S
N
N
CH3
NH2
O
NaOH
N
N N
NH2
SHR
+
O
R'
S
N
N
N N
R
R'
   (V)
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5.      Quinoline thiadiazepine derivatives (VI) have synthesized by R.Gururaja
         et al. 8 by condensation of 2-chloro-6-substituted quinoline-3-carboxaldehyde
        with thiocarbohydrazide in pyridine.
  (VI)
6.      T.E. Glotova et al. 9 have synthesized 1,3,4-thiadiazepine (VII) by treating a-
         acetylenic ketones  with  4-amino-3-mercapto-1,2,4-triazole in glacial acetic
       acid.
  (VII)
7.      Sinegibskaya A.D.et al. 10  have synthesized thiadiazepine (VIII) by reaction of
         4-amino-3-hydrazino-1,2,4-triazoline-5-thione with a and a-dicarbonyl
         compounds then the treatment of Br-CH2-CO-Ph.
(VIII)
Several methods have also documented in literature.1 1 - 1 4
N
CHOR
Cl
+
NH
NH
S
NH2
NH2
N
N
S
N
R
NH
NH2
Pyridine
N
N N
NH2
SHR
+
O
Ar
 R'
gla. ACOH
N
N
N
S
N
R
R'
Ar
N
N
H
N
NH2
S N
N
CH3
CH3
S
N
N
N N
N
N
CH3
CH3
Ph
BrCH 2COPh
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BIOLOGICAL EVALUATION
The various therapeutic activities of thiadiazepine derivatives have been
reported as under.
1.      Anti-HIV15
2.     Anticonvulsant 16
3.     CCK antagonists17
4.     Gastrin receptor antagonists18
5.     Antiviral19
6.     Antiarrythmic 20
7.      Antipsychotic 21
8.     Antitumor22
9.     Antidepressant 23
Khalil and Habib24  have documented antimicrobial and anticancer activities of
thiadiazepine derivatives. Marfe G. et al. 25  have investigated thiadiazepines useful as
anticancer agents. Giannotti D. and coworkers26  have screened thiadiazepines for their
antidepressant activity. U.V. Laddi and coworkers27  have prepared  thiadiazepines  (IX)
and tested  for their antimicrobial  and antituberculosis activities.
SN
N
NN
Z
C6H5
Ar
(IX)
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B.S. Holla and coworkers28  have investigated some thiadiazepines as potent
antimicrobial agents. Ammar Y.A. et al.2 9  have prepared triazole thiadiazepines as
antifungal agents. Swati Sharma and coworkers30  have discovered thiadiazepine
derivatives as possible potential drug for cancer metastatics. Borsini F. et al. 31  have
investigated thiadiazepines which is useful as potent antidepressant drugs. Denis Pires di
Lima32  have synthesized thiadiazepines (X) useful as an angiotensin-converting enzyme
(ACE) inhibitors and Bolos I. et al.3 3reported them as an important class of
antihypertensive drugs.
NH
COOH
N
S
N
O
COOH
(X)
R. Gururaja and coworkers34  have synthesized 1,3,4-thiadiazepines (XI) and
screened for their anthelmintic activity and antibacterial activity. B. Shivarama Holla et
al. 35  have documented antibacterial and antiviral activity of thiadiazepines. M. Kidwai et
al. 36  have reported thiadiazepines as potential antimicrobial agent.
N
N
S
N
R1
NH N
R2
      (XI)
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Ashutosh Singh and Nizamuddin37  have prepared thiadiazepines (XII) and reported
their mulluscicidal activity. Robert J. Cherney and coworkers38   have demonstrated
benzothiadiazepines as selective tumor necrosis factor a-converting enzyme inhibitors.
Cherney R.J. et al. 39  have synthesized thiadiazepines and reported them as selective
tumor necrosis factor alpha converting enzyme inhibitor.
OCH2
N N
N
N
S
CH3
CH3
R
   (XII)
In view of vast therapeutic activities of 1,3,4-thiadiazepines, it was
contemplated to synthesize some new thiadiazepine derivatives in search of agents
possessing higher biological activities with least side effect, which have been
described in following section.
SECTION-I           :        SYNTHESIS AND BIOLOGICAL SCREENING OF
         3-(m-CHLOROPHENYL)-9-AlkYL[1,2,4]TRIAZOLO
        [ 3 ' , 4 '  :  2 , 3 ] [ 1 , 3 , 4 ] T H I A D I A Z E P I N O [ 6 , 7 - b ]
        QUINOLINES
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
9 -ALKYL[1 ,2 ,4 ]TRIAZOLO[3 ' ,4 ' :2 ,3 ] [1 ,3 ,4 ]THIADIAZEPINO[6 ,7 -
b]QUINOLINES.
1,3,4-Thiadiazepine derivatives occupy a unique place in the field of medicinal
chemistry due to wide range of biological activities exhibited by them. To further assess
the potential of such class of compounds as good therapeutic agents, a series of 1,3,4-
thiadiazepines of type (V) was carried out by one step reaction of 4-amino-5-(m-
chlorophenyl)-4H-1,2,4-triazole-3-thiol 2-chloro-3-formylquinolines in presence of
K 2CO 3.
Type (V) R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro  biological assay
like antibacterial activity towards Gram positive and Gram negative bacterial strains
and antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml.
The biological activity of the synthesized compounds have been compared with
standard drugs. Some compounds have been found to have moderate activity as
compared to known antibiotics recorded on Graphical Chart No.5.
N
N
N
SH
NH2
Cl
+
N Cl
O
R
N N
N
Cl
N
S
N R
K2CO3
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 Observed
Alkane C-H str. (asym.) 2950 2975-2950 40
  -CH3 C-H str. (sym.) 2850 2880-2860 40
C-H def.(asym.) 1425 1470-1435 40
C-H def.(sym.) 1360 1385-1370 40
Aromatic C-H  str. 3065 3080-3030 40
C=C str. 1492 1520-1480 40
C-H i.p. (def) 1130 1125-1090 41
C-H o.o.p. (def) 829 835-810 40
Triazole C=N str. 1636 1640-1500 40
C-N str. 1157 1220-1020 42
N-N str. 1015 1050-1010 41
Thiadiazepine C-S-C str. 710 700-600 42
1086 1250-1000 42
Ether C-O-C str.(asym.) 1230 1275-1200 41
(Ar-O-R) C-O-C str.(sym.) 1061 1070-1000 41
Halide C-Cl str. 758 800-600 41
Type
    Ref.
        Reported
Frequency in cm-1 Vibration
Mode
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
-10.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
%T
600.0800.01000.01200.01400.01600.01800.02000.03000.04000.0
1/cm
 710.0
 785.0
 829.0
1015.5
1061.0
1086.0
1130.0
1157.0
1230.0
1282.6
1322.1
1360.0
1401.2
1425.3
1492.0
1574.8
1592.1
1610.0
1636.5
1654.8
1682.8
2850.6
2950.0
3065.0
3567.1
N N
N
Cl
N
S
N
OCH3
IR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-9-
M E T H O X Y [ 1 , 2 , 4 ] T R I A Z O L O [3 ' , 4 ' : 2 , 3 ] T H I A D I A Z E P I N O [ 6 , 7 -
b]QUINOLINE
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NMR SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-9-
METHOXY[1,2,4]TRIAZOLO[3',4':2,3]THIADIAZEPINO[6,7-b]QUINOLINE
1 3.98 3H singlet Ar-OCH3     -
2 7.19 1H doublet Ar-Hc     -
3 7.49-7.41 3H multiplet Ar-Hbhi     -
4 7.93-7.85 2H multiplet Ar-Hag     -
5 8.07 1H singlet Ar-Hf     -
6 8.77 1H singlet Ar-Hd     -
7 10.97 1H singlet Ar-He     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
N
S
N
OCH3
g
h
i
f
e
d
c
b
a
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MASS SPECTRAL STUDIES OF 3-( m-CHLOROPHENYL)-9-
METHOXY[1,2,4]TRIAZOLO[3',4':2,3]THIADIAZEPINO[6,7-b]QUINOLINE
Expanded aromatic region of NMR spectra
N N
N
Cl
N
S
N
OCH3
N N
N
Cl
N
S
N
OCH3
g
h
i
f
e
d
c
b
a
M/Z= 393
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-
9-ALKYL[1 ,2 ,4 ]TRIAZOLO[3’ ,4 ’ :2 ,3 ] [1 ,3 ,4 ]THIADIAZEPINO[6 ,7 -
b]QUINOLINES
[A]     Preparation of potassium-m-chlorobenzyl dithiocarbamate.
See Part-I, Section-I [A].
[B]     Preparation of 5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols.
See Part-I, Section-I [B].
[C]     Preparation of substituted 2-chloro-3-formylquinolines.
These were prepared by the condensation of substituted acetanilide with  DMF /
POCl3 using well known Wielsmayerhacck rearrangement.
[D] Preparation of 3-(m-chlorophenyl)-9-methoxy[1,2,4]triazole[3’,4’:2,3]
[1,3,4]thiadiazepine[6,7-b]quinoline.
To a mixture of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol (2.26g,
0.01 mol) and 2-chloro-3-formyl-6-methoxyquinoloine (2.07g, 0.01 mol) in dry DMF
(20 ml) anhydrous K2CO 3 (2.0g) was added. Then the reaction mixture was stirred at
70-80oC for 4 hrs. The content was cooled and poured onto crushed ice. The product
was  isolated and crystallized from methanol. Yield 54%, m.p. 274oC. Anal.Calcd. for
C19H12ClN 5OS: C, 57.94; H, 3.07; N, 17..78 %; Found: C, 57.90; H, 3.03; N, 17.75%.
Similarly other substituted thiadiazepines were prepared. The physical constants
are recorded in Table No.5.
[E]       Antimicrobial of  3-(m-chlorophenyl)-9-alkyl[1,2,4]triazole[3’,4’:2,3]
             [1,3,4]thiadiazepine[6,7-b]quinoline.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical Chart No.5.
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    PART - V
STUDIES ON
SULPHONAMIDES
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INTRODUCTION
The invention of sulphonamides arouse from an early claim that
sulphonamide group increased the chemotherapeutic era by making possible a direct
attack on microbial infection. 1  Sulphonamide was first synthesized by Glemo in
1908. Gerhald Domagk in 1935 tested protonsil towards infection by hemolytic
streptococci and found it very effective antibacterial which led to the synthesis of
newer molecules by incorporating different nucleus.
Sulphonamides have the general formula of R-SO2-N-R’-R’’ where R=organic
radical, R’ and R’’= hydrogen or organic radical. Depending upon the nature of R, the
sulphonamides are classified as aliphatic, aromatic and heterocyclic. The aliphatic
sulphonamides have not yet become important. Aromatic and heterocyclic sulphonamides
have achieved great commercial significance. Sulphonamides continue to be used as an
antibacterial because they are effective, inexpensive and free of super infection problems
of the broad spectrum antibiotics.2
SYNTHETIC ASPECT
Various methods have been reported for the synthesis of sulphonamides in
literature.3-5
1. Natesan Murugesan et  al. 6 have prepared sulphonamide derivatives and studied
their biological activity.
2. Some novel sulphonamide derivatives (1) have synthesized by Wa, Chengde
and coworkers. 7
         (I)
O
O
O
S
Me
SO2Cl O
Me
Cl
NH2
Pyridine
-HCl
O
OMe
O
S
SO2.NH
O
Me
Cl
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BIOLOGICAL EVALUATION
Some sulphonamide derivatives are recently in clinical use are listed below.
NN
NH
SO2
NH2
OCH 3
H3CO
SO2NH 2
SO2NH2
Cl
SO2
N
Ag N
NH2
S
NH N
N
NH2
O
O
F
OCH 3
CH3
NHCOCH 2 S NH
N
CH3
CH3
O
O
Suplhadoxine      Clofenamide
     Antimalarial             Diuretic
 Silver Sulphadiazine          Sulphadiazine
   Antimicrobial in burns Antibacterial
Gliflumide
Antidiabatic
Monograms and review, 8,9  surveying various aspects of sulpha drugs have
been published. Considerable research has been done to extend the activity and to
reduce the toxicity of sulpha drugs.
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Several sulphonamide derivatives have been reported to be associated with
diverse biological activities are listed as under.
1. Diuretic1 0
2. Hypoglycemic 1 1
3. Herbicidal1 2 , 1 3
4. Antihypertensive1 4
5. Anticonvulsant1 5
6. Antimalarial1 6
7. Antiviral1 7
8. Anti-HIV1 8 , 1 9
9. Antiinflammatory2 0 , 2 1
10. Antitumor2 2 , 2 3
Mengelers M. J. et al. 24  have synthesized some new sulphonamide derivatives
and reported their in vitro  antimicrobial activity. Some new sulphonamide derivatives
(II) have discovered by Jim A.Turpin and coworkers25  which are used as an anti-HIV
agents.
S
S
C
O
NH SO2
NH
N
O
CH3
C
O
NH SO2
NH
N
O
CH3
(II)
Thaisrivongs S. and coworkers26  have synthesized sulphonamide derivatives
and reported them as a novel HIV protease inhibitors. Cooper and coworkers27  have
prepared sulphonamide derivatives (III)  and documented  their antipsychotic
activity.
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SO2
NH
NH
      (III)
Maillard J Y. et al. 28  have documented antimicrobial activity of sulphonamide
derivatives. Casini A. and coworkers2 9  have documented anticancer activity of
sulphonamide derivatives. De Clercq E. et al.30  have reported anti-HIV activity of
sulphonamide derivatives. Some novel sulphonamides (IV) prepared by Morohashi,
Hirohiso and coworkers31  and studied their pharmacological activity and has been found
as anticancer agent.
S
NH
NH
N
O
O
CH3
O
O
 (IV)
Scozzafava A and coworkers 32  have reported sulphonamide derivatives as
anticancer and antiviral agents. Supuran CT.et al. 3 3  have documented anticancer,
antiinflammatory and antiviral activity of sulphonamide derivatives. Dieter B.and
coworkers 34  have reported antibacterial activity of the sulphonamides. Supuran CT.et
al. 35  documented antiviral activity of sulphonamide derivatives.
Dominguez J N et al. 36  have synthesized some novel sulphonamides and reported
their antimicrobial activity. Bialk H M and coworkers37  have documented antimicrobial
activity of some sulphonamide derivatives.
Link J T, Sorensen B, Jacobson P B. and coworkers38  have documented
antidiabetic activity of sulphonamides. Tortorano A M. et al. 39  reported fungicidal activity
of sulphonamide derivatives.
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In the past years considerable evidence has been accumulated to demonstrate
the pharmacodynamic and chemotherapeutic activities of sulphonamide derivatives. To
further assess the potential of such type of compounds, study of sulphonamide derivatives
have been carried out as described under.
SECTION-I             : SYNTHESIS AND BIOLOGICAL SCREENING OF
3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL ARYL SULPHONAMIDES.
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-5-
MERCAPTO-4H-1,2,4-TRIAZOL-4-YL ARYLSULPHONAMIDES.
Looking to the interesting properties of sulphonamides, it was considered
worthwhile to synthesize a series of sulphonamide derivatives of type (VI) for obtaining
biologically potent molecules by the condensation of 4-amino-5-(m-chlorophenyl)-4H-
1,2,4-triazole-3-thiol with different carboxy arylsulphonyl chloride in pyridine.
N
N
N
Cl
NH2
SH
R - SO2 - Cl
Pyridine
N
N
N
Cl
NH
SO2
R
SH
Type (VI) R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all  the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro  biological assay
like antibacterial activity towards Gram positive and Gram negative bacterial strains
and antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml.
The biological activity of the synthesized compounds have been compared with
standard drugs. Some compounds have been found to have moderate activity as
compared to known antibiotics recorded on Graphical Chart No.6.
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 Observed
Alkane C-H str. (asym.) 2934 2975-2950 40
  -CH3 C-H str. (sym.) 2851 2880-2860 40
C-H def.(asym.) 1468 1470-1435 40
C-H def.(sym.) 1381 1385-1370 40
Aromatic C-H  str. 3068 3080-3030 40
C=C str. 1497 1520-1480 40
C-H i.p. (def) 1121 1125-1090 41
C-H o.o.p. (def) 813 835-810 40
Triazole C=N str. 1588 1640-1500 40
C-N str. 1121 1220-1020 42
N-N str. 1041 1050-1010 40
Sulphonamide -NH str. 3410 3350-3000 40
-SO 2 1310 1350-1300 40
Halide C-Cl str. 78 800-600 40
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL -(p-METHYLPHENYL)SULPHONAMIDE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
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NMR SPECTRAL STUDIES OF 3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL -(p-METHYLPHENYL)SULPHONAMIDE
1 2.44 3H singlet Ar-CH3     -
2 7.31 2H doublet Ar-Haa ’ Jab=8.1
3 7.40-7.48 2H doublet Ar-Hfg Jfe=7.8
Jfg=7.8
4 7.78-7.76 2H doublet Ar-Hbb ’ Jba=8.1
5 7.90 1H doublet Ar-He Jef=7.2
6 8.00 1H singlet Ar-Hd     -
7 9.97 1H singlet Ar-Hc     -
8 14.01 1H broad Ar-Hh     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
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S
O
O
CH3
SH
e
f
g
d
a
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b
b'
h
c
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MASS SPECTRAL STUDIES OF  3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL -(p-METHYLPHENYL)SULPHONAMIDE
Expanded aromatic region of NMR spectra
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-CHLOROPHENYL)-5-
M ERCAPTO-4H-1,2,4-TRIAZOL-4-YL ARYL SULPHONAMIDES.
[A]       Preparation  of  potassium-m-chlorobenzyl dithiocarbamate.
           See Part-I, Section-I (A).
[B]       Preparation of 5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols.
           See Part-I, Section-I (B).
[C]      Preparation of 3-(m-chlorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl-p-
             methylphenyl sulphonamide.
A mixture of p-tolylsulphonylchloride (1.90g, 0.01 mol) and 5-(m-chlorophenyl)-
4-aryl-4H-1,2,4-triazole-3-thiols (2.26g, 0.01 mol ) was refluxed in dry pyridine for 4-
5 hrs. The product was isolated and recrystallised from ehanol. Yield 70 %, m.p. 240oC.
Anal.Calcd. for C15H 13ClN 4S2O 2: C,47.30; H,3.44; N,14.71% ; Found: C,47.27;
H,3.43; N,14.69 %.
Similarly other sulphonamides have synthesized and physical constants are
recorded in Table No.6.
[D]      Antimicrobial activity of 3-(m-chlorophenyl)-5-mercapto-4H-1,2,4-
           triazol-4-yl  aryl sulphonamides.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical Chart No.6.
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    PART - VI
STUDIES ON
ARYLAMIDES
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INTRODUCTION
The Characteristic group present in the simple carboxylic amide is –CONH2.
They are the acyl substitution products of ammonia. Many natural products are amides,
urea, diamides of carbonic acid. The peptides and proteins are linear structure of cyclic
polyamides. The alkaloids of pepper, piperidine and chavicine are N-substituted amides
of unsaturated acid. N-isobutyl amides of certain highly unsaturated aliphatic acids occur
in plants, shows insecticidal activity1.  Amides derived from polyacetylenic acid have
been isolated from certain fungi2.
SYNTHETIC ASPECT
         Various methods for the synthesis of aryl acetamides are described in literature3-8.
Marayama Tatsuya, Suzuki Onda9 have synthesized arylamide (I) as under.
NH
NH2
OH
Ph
N
N
Cl
Cl
O
Cl
N
N
NH
O
NH
OH
Ph
Pyridine
(I)
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BIOLOGICAL EVALUATION
Amides and substituted amides have widely been used as pharmacologically useful
entities. Some arsano organometallic compounds like tryparsamide and arsacetin having
amide group have proved to be successful chemotherapeutic agents. The biological
activities of aryl amide derivatives have been reported as under.
1. Anticonvulsant 10
2. Antiallergic11
3. Herbicidal12
4. Cardiotonic 13
5. Antimicrobial14,15
6. Analgesic 16
7. Antiulcer17
8. MAO inhibitor18
9. Anticancer19,20
10. Antiinflammatory21
11. Anti-HIV22
12. Sodium channel blockers23
Sanderson Philip E.J. et al.24  have synthesized aryl amides and studied their
biological activity. Moloney et al. 25  have reported aryl amide derivatives as antiulcer
agents. Foster James et al. 26  have synthesized some new amide derivatives as potent
anticonvulsant. Mulik et al. 27  have studied some aryl amides shows antibiotic activity.
Bridge Gory28  et al. have screened arylamides as anti-HIV agent. Laura and co-workers29
have prepared arylamides as antibacterial agents. Hobbs et al. 30  have designed some
amides (II) and reported them as MCH-receptor antagonist.
Arylamides...
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Cl
Cl
NH O
NH NH
(II)
A.K. Mallams31  has reported arylamide derivatives as antitumor agent. More
over S. J. Laulloo et al. 32  and J. Hazarika33  have prepared some novel biologically active
arylamide derivatives and reported them as antimicrobial agents. Dhanak Dushyant et
al. 34  have synthesized arylamide (III) useful as urotensin-II antagonist.
Cl
Cl
O
NH
N N S
O
O
O
N
H
(III)
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Tabuchi et al. 35  have screened arylamide derivatives as novel potent antagonist
of human neuropeptide YY5 receptor. Chan
36  have recorded substituted benzophenone
arylamide derivatives as inhibitor reverse transcriptase. Pieters et al. 37  have synthesized
new diazene carboxamides (IV) as anticancer agents. Anthony and co-workers38  have
investigated amides as anti-HIV. Chen et al. 39  have reported arylamides (V) as antitumor
agents.
James B. and co-workers40  have screened arylamides as selective opioid-K
receptor antagonist. Fanrong mu et al. 41  have demonstrate new arylamide (X) as
anticancer. Bin Ho et al. 42  have investigated arylamide derivatives (XI) as anticonvalsant
agent. Cudahy et al. 43  have prepared arylamide (XII) and reported them as antiviral
agent.
NH
N
O
N
F F
F
FF
N NH
F
NH
O
CF3
N
Me
Me
(IV)
(V)
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OH
OH
NH
OH
O
NH
F
NHCH3
O
NH2
O
N
O N
Me
O
NH
O
Cl
(X)
(XI)
(XII)
In the past years, considerable evidence have been accumulated to demonstrate
the pharmacodynamic and chemotherapeutic activities of amide derivatives. To further
assess the potential of such type of compounds, the synthesis have been carried out
which have been described as under.
SECTION-I    : SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(m-
CHLOROPHENYL)-5-MERCAPTO-4H-1,2,4-TRIAZOL-4-
YL ARYLAMIDES
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 3-(3-CHLOROPHENYL)-5-
MERCAPTO-4H-1,2,4-TRIAZOL-4-YL ARYLAMIDES
Arylamide  derivatives are associated with broad spectrum of pharmacological
activity. With an intension of preparing the compounds possesing better therapeutic
activity,arylamides of type-(VII) have been synthesised by the condensation of 4-amino-
5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with different aromatic acid chlorides.
N N
N
NH2
SH
Cl
R-CO-Cl
Pyridine
N N
N
NH
SH
Cl
R
O
Type (VII) R = Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.7.
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 Observed
Aromatic C-H  str. 3062 3080-3030 44
C=C str. 1510 1585-1480 44
C-H i.p. (def) 1091 1125-1090 45
C-H o.o.p. (def) 818 835-810 45
Triazole C=N str. 1605 1650-1580 46
C-N str. 1233 1220-1020 46
N-N str. 1020 1050-1010 45
Ether C-O-C str.(asym.) 1233 1275-1200 46
(Ar-O-R) C-O-C str.(sym.) 1002 1070-1000 46
Amide -NH str. 3220 3300-3100 44
-CO-NH -NH def 1578 1650-1580 44
C=O str. (Amide) 1685 1690-1630 44
Halide C-Cl str. 729 800-600 45
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL - (p-METHOXYPHENYL)AMIDE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
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NMR SPECTRAL STUDIES OF 3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL - (p-METHOXYPHENYL)AMIDE
1 3.87 3H singlet Ar-OCH3     -
2 6.95 2H doublet Ar-Hbb ’ Jba=8.4
3 7.41-7.46 2H doublet Ar-Hfg Jfe=7.5
Jfg=7.8
4 7.82 2H doublet Ar-Haa ’ Jab=8.7
5 7.88 1H doublet Ar-He Jef=7.2
6 8.00 1H singlet Ar-Hd     -
7 9.84 1H singlet -NH     -
8 13.90 1H broad -SH     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
SH
NH
O
OCH3
e
f
g
d c
a'
a
b'
b
h
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MASS SPECTRAL STUDIES OF 3-(m-CHLOROPHENYL)-5-MERCAPTO-4H-
1,2,4-TRIAZOL-4-YL -(p-METHOXYPHENYL)AMIDE
Expanded aromatic region of NMR spectra
N N
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF  3-(m-CHLOROPHENYL)-
5-M ERCAPTO-4H-1,2,4-TRIAZOL-4-YL ARYLAMIDES
[A]       Preparation of potassium-m-chlorobenzyl dithiocarbamate.
           See Part-I, Section-I (A).
[B]       Preparation of 5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols.
           See Part-I, Section-I (B).
[C]      Preparation of 3-(m-Chlorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl-p-
           methoxy phenylamide.
A mixture of p-methoxybenzoylchloride (1.70g, 0.01 mol) and 5-(m-
chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols (2.26g, 0.01 mol ) was refluxed in dry
pyridine for 8 hrs. The product was isolated and crystallised from ehanol. Yield 70 %,
m.p. 180oC. Anal.Calcd. for C16H13ClN 4SO2: C,53.26; H,3.63; N,15.53% ; Found:
C,53.22; H,3.60; N,15.50 %.
Similarly other arylamides have synthesized and physical constants are recorded
in Table No.7.
[D]      Antimicrobial activity of 3-(m-chlorophenyl)-5-mercapto-4H-1,2,4-
           triazol-4-yl arylamides.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical Chart No.7.
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    PART - VII
STUDIES ON
MANNICHBASES
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INTRODUCTION
Mannich bases containing bridged N-atom exhibit pronounced biological
activities. The study of mannich reaction attracted a great deal of attention to the chemists
because it plays a vital role owing to their wide range of industrial applications. Mannich
bases are also employed as intermediate in chemical synthesis.1-3
Mannich bases possess diverse pharmacological action like antibacterial,
antimalarial and analgesic. Several therapeutic important molecules prepared through
mannich reactions have received more attention in recent years.4-6 Mannich bases have
gained important because of their technological applications in polymer chemistry, 7
especially as paints and surface active agents and exhibits complexation characteristic
with many transition metal ions.
Over the years there has been much controversy about the mechanism of the
mannich reaction especially as to whether the aldehyde is first attacked by active
hydrogen compound or by ammonia or amine. Studies of the reaction kinetics have led
to the following mechanistic proposals.
The Base-Catalysed Reaction:
    (I)
The Acid-Catalysed Reaction:
      (II)
O
HH
+ R 2.NH H H
N.R2
OH
+ CH3
O
R1 H H
N.R2
O
R1
O
HH
+ R2.NH H H
N.R 2
OH
N.R 2
H H
++ CH2
O H
R 1
-
H
H
OH
R 1
N.R 2
+
H
H
O
R1
N.R 2
H
+
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SYNTHETIC ASPECT
Different methods have cited in literature to synthesize mannich bases by several
workers 8-9 using various interesting substractes.
1. Seshaiah Krishnan  et al. 10  have synthesized mannich bases (III) from the
schiff bases of isatin in presence of formaldehyde and diphenyl amine.
(III)
R= H,Cl,Br
R1= C 6H5Br, C6H5CH3,C6H5OCH3
R2= H,-CH2-(NC6H5)2
2. Afaf H. El-masry, H.H.Fahmy and coworkers11  have synthesized mannich
base derivatives (IV) by the condensation of 5-[2-(2-methylbenzimidazole-
1-yl)ethyl][1,3,4]oxadiazole-2(3H)-thione with different secondary amine in
the presence of formaldehyde and also reported their antimicrobial activity.
      (IV)
3. Pandeya and  Sriram D.1 2   have  synthesized  mannich  bases  by  the
condensation of the acidic group of isatin with formaldehyde and secondary
amines.
N
H
O
N.R1R
HCHO
NH
C6H5
C6H5
N O
N.R1R
R2
N
N
CH2 CH2
N
O
NH
S
CH3 ry
2 amine
HCHO
N
N
CH2 CH2
N
O
N
S
CH3
CH2.R
NH O NH N CH3N(C2H5)2R = , ,
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4. Venkatesha    Prabhu    G.    and     Vankappayya   D. 13  have    synthesized
aminobenzylated mannich bases (V) and (VI) by the condensation reaction
between heterocyclic secondary amines and benzaldehyde.
    (V)         (VI)
         X= CH2, O
5. Gadre J.N. and coworkers have synthesized mannich bases of 8-alkyl-7-
hydroxy coumarin.
6. Fox, Raymond C. et al. 15  have reported the preparation of some novel metal
selective mannich bases.
BIOLOGICAL IMPORTANCE
Mannich bases are associated with a wide varieties of biological activities and
industrial applications such as,
1. Antifungal16
2. Antitumor17
3. Antibacterial18
4. Antipsychotic 19
5. Cytotoxic 20
6. Anti-inflammatory21
7. Antileishmanial22
Recently Surendra Pandeya , Shivkumar Smitha et al. 23  have synthesized some
new mannich base  derivatives (VI) of  isatin and  reported  their biological
CHO
+
X NH
X OH
CH3
NH2
O
NH2
X N NH C
O H
N X
CH3
activities. N.J.Gaikwad and coworkers24 have synthesized mannich bases of 4-
thiazolidinone (VIII) anticonvulsant activity of all the synthesized compounds have
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also been evaluated. Haydar Yuksek et al. 25  have also prepared novel mannich bases
(IX).
       (VII)                                       (VIII)
R= H,Br R= H, Cl, CH3
R
1
= Piperidino, morpholino
    (IX)
R= H,CH3, OCH3
B.Shivarama Holla et al. 26  have prepared mannich bases and tested them for
anthelmintic activity (X) and all the newly synthesized compounds were tested for their
antibacterial and antifungal activity (XI).
    (X)                                                              (XI)
Movrin M, Maysinger D. and coworkers 27  have synthesized mannich bases from
nitroxoline and reported them as biologically active agents. Erol D. D.et al.28  have
synthesize some novel mannich base derivatives from 6-acyl-3-(3,5-dimethylpiperidino
methyl)-2(3H)-benzooxazolones and reported their biological activities. H.M.Hassan
and S.A.M. Shedid 29  have synthesized some new mannich bases and reported
antimicrobial activity of some novel mannich bases containing 1,8-napthyridine moiety
(XII).
N O
O
N.R1
R
S
NH
R1
O
R
N
R2
R3
N
N
N N
O
H3COC
R
O
N
NN
N N CH3
N
R
S
O
O2N
OCH3
N
NN
N O
N
R
S
O
O2N
OCH3
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(XII)
                      X= CH2, O, N-CH3
Scott MK, Martin GE and coworkers 31  have reported some pyrrole mannich
bases as potential antipsychotic agents. Gul HI, Ojanen T and coworkers32  have reported
antifungal activity of some mono, bis and quaternary mannich bases derived from
actophenone. Li Y, Yang Z S  et al. 33  have synthesized some mannich base derivatives
and reported their antimalarial activity.
Lorand T, Kocsis B and coworkers34  have synthesized some new mannich ketones
and reported their antibacterial activity. Sriram D et al. 35  have reported synthesis,
antibacterial, antifungal and anti-HIV evaluation of schiff and mannich bases of isatin
and their derivatives with triazole. Seshaiah Krishnan, Sridhan and coworkers36  have
synthesized some new mannich base derivatives and reported that mannich bases exhibit
higher antibacterial activity than the corresponding schiff base.
Gul H I, Ojanen T et al. 37  have documented antifungal activity of bis mannich
bases derived from acetophenones. Gul H I, Calis U and coworkers38  have synthesize
some mono mannich bases and evaluate their anticonvulsant activity. Shingare M.S. et
al. 39  have described the synthesis and the antiviral activity of mannich bases (XIII).
NN NH
N
N
N
X
O
OCH 3
R
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(XIII)
R= H,4-Me, 5-OMe, 5-Cl, 6-Br
H.S.Joshi et al.40  have been synthesized some novel amino benzylated mannich
bases and reported  their antimicrobial activities.
In view of the importance of mannich bases as versatile synthetic intermediates
and the availability of scanty literature on therapeutic properties, we have undertaken
the preparation of mannich bases in following sections.
N
N
NH
N
S
N
S
S
R
R
SECTION-I      : SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-
CHLOROPHENYL)-4-{[(1E)-(4-ARYL)METHYLENE]
AMINO}-4H-1,2,4-TRIAZOLE-3-THIOLS
SECTION-II    : SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-
CHLOROPHENYL)-2-{[(BIS-ARYL/ ALKYL)AMINO]
METHYL}-4-{[(1-E)-(4-ARYL)METHYLENE]AMINO}-
2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONES
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
4-{[(1E)-(4-ARYL)METHYLENE]AMINO}-4H-1,2,4-TRIAZOLE-3-THIOLS
Schiff’s bases possess a wide range of therapeutic activities and intermediate for
many heterocyclic compounds, hence it appeared of interest to synthesize some new
Schiff bases of type (VIII) in association with 1,2,4-triazole nucleus. It has been prepared
by the condensation of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol with
different aromatic aldehydes in the presence of glacial acetic acid.
N
N
N
NH2
SH
Cl
N
N
N
N
SH
Cl
R
R-CHO
gl. AcOH
Type  (VIII)   R= Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.8.
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 Observed
Alkane C-H str. (asym.) 2926 2975-2950 41
  -CH3 C-H str. (sym.) 2858 2880-2860 41
C-H def.(asym.) 1465 1470-1435 41
C-H def.(sym.) 1385 1385-1370 41
Aromatic C-H  str. 3071 3080-3030 42
C=C str. 1560 1585-1480 42
C-H i.p. (def) 1145 1125-1090 42
C-H o.o.p. (def) 815 835-810 43
Triazole C=N str. 1620 1640-1500 43
C-N str. 1145 1220-1020 42
N-N str. 1035 1050-1010 43
Ether C-O-C str.(asym.) 1271 1275-1200 43
(Ar-O-R) C-O-C str.(sym.) 1035 1075-1020 42
Schiff’s base -C=N str. 1610 1660-1580 41
Halide C-Cl str. 760 800-600 42
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 5-(m-CHLOROPHENYL)-4{[(1E )-4-( p-
METHOXYPHENYL)METHYLENE]AMINO}-4H-1,2,4-TRIAZOLE-3-
THIOL
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
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1035.9
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1259.4
1271.0
1339.5
1360.7
1385.8
1436.9
1465.8
1498.6
51881554.5
1582.5
1610.0
1623.0
1647.1
2361.0
2753.2
2858.3
2888.2
2926.8
3071.0
N N
N
Cl
SH
N
OCH3
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NMR SPECTRAL STUDIES OF 5-(m-CHLOROPHENYL)-4{[(1 E )-4-( p-
METHOXYPHENYL)METHYLENE]AMINO}-4H-1,2,4-TRIAZOLE-3-THIOL
1 3.89 3H singlet Ar-OCH3     -
2 7.01 2H doublet Ar-Haa ’ Jab=8.7
3 7.45 2H doublet Ar-Hfg Jfe=6.9
4 7.83 2H doublet Ar-Hbb ’ Jba=8.7
5 7.88 1H doublet Ar-He Jef=6.9
6 7.99 1H singlet Ar-Hd     -
7 9.76 1H singlet Ar-Hc     -
8 14.00 1H broad Ar-Hh     -
Signal
  No.
Signal Position
    (d ppm)
Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
SH
N
OCH3
e
f
g
d
b
b'
a
a'
h
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MASS SPECTRAL STUDIES OF 5-(m-CHLOROPHENYL)-4{[(1E )-4-(p-
METHOXYPHENYL)METHYLENE]AMINO}-4H-1,2,4-TRIAZOLE-3-THIOL
Expanded aromatic region of NMR spectra
N N
N
Cl
SH
N
OCH3
N N
N
Cl
SH
N
OCH3
e
f
g
d
b
b'
a
a'
h
M/Z= 344
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
4-{[(1E)-(4-ARYL)METHYLENE]AMINO}-4H-1,2,4-TRIAZOLE-3-THIOLS
[A]      Preparation of potassium-m-chlorobenzyl dithiocarbamate.
          See Part-I, Section-I (A)
[B]      Preparation of 5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols.
          See Part-I, Section-I (B)
[C] Preparation of 5-(m-chlorophenyl)-4-{[(1E)-(p-methoxyphenyl)
methylene]amino}-4H-1,2,4-triazole-3-thiol.
To a solution of 4-amino-5-(m-chlorophenyl)-4H-1,2,4-triazole-3-thiol (2.26g,
0.01 mol) in DMF (10 ml), p-anisaldehyde (1.36g, 0.01 mol) was added with constant
stirring. To this mixture 1.0 ml glacial CH3COOH (1.0 ml) was added as a catalyst. The
reaction mixture was refluxed for 8 hrs. The content were cooled and poured onto crushed
ice and triturated with sodium bisulphate solution. The product was isolated and
crystallized from methanol. Yield 70%, m.p. 213oC, Anal. Calcd. For C16H13ClN 4OS:
C, 55.73; H, 3.80; N, 16.25 %; Found: C, 55.70; H, 3.76; N, 16.21 %.
Similarly other aromatic aldehydes were condensed. The physical constants are
recorded in Table No.8.
[D] Antimicrobial activity of 5-(m-chlorophenyl)-4-{[(1E)-(4-aryl)
methylene]amino}-4H-1,2,4-triazole-3-thiols.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical Chart No.8.
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SECTION-II
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
2 - { [ ( 4 - S U B D T I T U T E D ) A M I N O ] M E T H Y L } - 4 - { [ ( 1 - E ) - ( 4 -
ARYL)METHYLENE]AMINO}-2,4-DIHYDRO-3 H-1,2,4-TRIAZOLE-3-
THIONES
In view of getting better therapeutic agent and considering the association of
various biological activity with triazole nuclei, the preparation of mannich bases of type
(IX) have been undertaken from 5-(m-chlorophenyl)-4-{[(1 E ) - (4-
aryl)methylene]amino}-4H-1,2,4-triazole-3-thiols with primary / secondary amines and
formaldehyde in dioxane.
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.9.
N
N
N
N
S
Cl
R
N
R1
R2
N
N
N
N
SH
Cl
R
NH
R1
R2
R NH2
HCHO
Type  (IX)   R= Aryl
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 Observed
Alkane C-H str. (asym.) 2932 2975-2950 41
  -CH3 C-H str. (sym.) 2847 2880-2860 41
C-H def.(asym.) 1429 1470-1435 41
C-H def.(sym.) 1358 1385-1370 41
Aromatic C-H  str. 3067 3080-3030 42
C=C str. 1513 1585-1480 42
C-H i.p. (def) 1071 1125-1090 43
C-H o.o.p. (def) 837 835-810 43
Triazole C=N str. 1605 1650-1500 42
C=S str. 1256 1250-1050 41
663 750-700 41
C-N str. 1160 1220-1020 42
N-N str. 1032 1050-1010 43
Ether C-O-C str.(asym.) 1256 1275-1200 42
(Ar-O-R) C-O-C str.(sym.) 1001 1075-1020 42
Halide C-Cl str. 744 800-600 41
Type     Ref.        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 5-( m-CHLOROPHENYL)-2-[4-( p-
C H L R O A N I L I N O M E T H Y L ) ] - 4 - { [ ( 1 - E ) - [ 4 - ( p -
METHOXYPHENYL)METHYLENE]AMINO}-2,4-DIHYDRO-3H -1,2,4-
TRIAZOLE-3-THIONE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
 
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cm
 532.3
 624.9
 635.5
 663.5
 726.1
 744.5
 837.0
 945.1
 962.4
1001.0
1032.0
1071.2
1160.8
1256.5
1358.8
1429.8
1444.6
1513.3
1569.9
1605.6
2847.7
2932.6
3067.6
N
N
N
Cl
S
N
O C H3
NH
Cl
Mannich bases...
162Studies on Medicinally...
NMR SPECTRAL STUDIES OF 5- ( m-CHLOROPHENYL)-2- [4 - ( p-
C H L O R O P H E N Y L ) A M I N O M E T H Y L ) ] - 4 - { [ ( 1 - E ) - [ 4 - ( p -
METHOXYPHENYL)METHYLENE]AMINO} -2 ,4 -DIHYDRO-3 H  - 1 , 2 , 4 -
TRIAZOLE-3-THIONE
1 3.86 3H singlet Ar-OCH3     -
2 5.63 2H singlet Arh     -
3 6.86 2H doublet Ar-Ha,a ’     -
4 6.99 2H doublet Ar-Hj,k ’     -
5 7.16 2H doublet Ar-Hb,b ’     -
6 7.35-7.46 3H multiplet Ar-Hf,g,c     -
7. 7.78-7.81 2H doublet Ar-Hk,k ’     -
8. 7.94 1H doublet Ar-Hd     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
N N
N
Cl
S
N
OCH3
NH
Cl
e
f
g
d
b
b'
a
a'
h
c
i
j
j '
k
k'
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MASS SPECTRAL STUDIES OF 5-( m-CHLOROPHENYL)-2- [4 - ( p-
C H L O R O P H E N Y L ) A M I N O M E T H Y L ) ] - 4 - { [ ( 1 - E ) - [ 4 - ( p -
METHOXYPHENYL)METHYLENE]AMINO} -2 ,4 -DIHYDRO-3 H  - 1 , 2 , 4 -
TRIAZOLE-3-THIONE
Expanded aromatic region of NMR spectra
N N
N
Cl
S
N
OCH3
NH
Cl
M/Z= 484
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 5-(m-CHLOROPHENYL)-
2 - { [ ( 4 - S U B D T I T U T E D ) A M I N O ] M E T H Y L } - 4 - { [ ( 1 - E ) - ( 4 -
ARYL)METHYLENE]AMINO}-2,4-DIHYDRO-3 H-1,2,4-TRIAZOLE-3-
THIONES
[A]      Preparation of  potassium-m-chlorobenzyl dithiocarbamate.
          See Part-I, Section-I (A)
[B]      Preparation of  5-(m-chlorophenyl)-4-aryl-4H-1,2,4-triazole-3-thiols.
          See Part-I, Section-I (B)
[C] Preparation of 5-(m-chlorophenyl)-4-{[(1E)-(4-aryl)methylene]amino}-
4H-1,2,4-triazole-3-thiols
See Part-(VII), Section-I (C)
[D] Preparation of  5-(m-chlorophenyl)-2-[4-(p-chlorophenyl)aminomethyl-4-
{[(1-E)-4-(p-methoxyphenyl)methylene]amino}-2,4-dihydro-3H-1,2,4-
triazole-3-thione.
To a  so lu t ion  of  5- (m-chlorophenyl ) -4-{[ (1 E ) -4 - (p -methoxyphenyl )
methylene]amino}-4H-1,2,4-triazole-3-thiol  (3.44g, 0.01 mol), formaldehyde (0.3g,
0.01 mol) and p-chloroaniline (1.28g, 0.01 mol) in dioxane (50 ml) was added. The
mixture was stirred for 24 hrs. and left overnight in a freeze. The solution was poured
onto crushed ice. The product was isolated, dried and recrystallised from dioxane Yield
50%, m.p. 220 oC. Anal. Calcd. For C 23H19Cl2N 5OS: C, 57.03; H, 3.95; N, 14.46 %;
Found: C, 57.00; H, 3.91; N, 14.42 %.
Similarly other amines condensed with 4-benzal-amino triazoles. The physical
constants are recorded in Table No.9.
[E] Antimicrobial activity of 5-(m-chlorophenyl)-2{[(4-substituted) amino]
methyl}-4-{[(1-E)-(4-aryl)methylene]amino}-2,4-dihydro-3H-1,2,4-
triazole-3-thiones.
Antimicrobial testing was carried out as described in Part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical Chart No.9.
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    PART - VIII
STUDIES ON
OXADIAZOLES
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INTRODUCTION
Oxadiazoles belong to an important group of heterocyclic compounds having
a toxophoric –N=C-O- linkage. It is well documented that oxadiazole system
contains the following members which are numbered by designating the hetero atoms
at particular position.
   (I)       (II)        (III)  (IV)
1,3,4-Oxadiazole is a heterocyclic molecule with oxygen atom at 1 and two
nitrogen atoms at 3 and 4 position. 1,3,4-Oxadiazole is a thermally stable aromatic
molecule1. They have been known for about 80 years it is only in the last decade
that investigations in this field have been intensified. This is because of large number
of applications of 1,3,4-oxadiazoles in the most diverse areas viz.drug synthesis,
dye stuff industry, heat resistant materials, heat resistant polymers and scintillators.
Reviews of the relevant literature prior to 1965 are available2 .
SYNTHETIC ASPECT
Most 1,3,4-oxadiazoles are best obtained by synthesis from acyclic precursors.
Such reactions are ‘one bond’ or ‘two bond’ cyclization. Different methods for the
synthesis have been cited in literature.3-10
1.        Hansong Chen et al. 11  have synthesized oxadiazoles by the reaction of
           hydrazide and aromatic acid in presence of POCl3.
(V)
O
N
N
O
N
N
O
N N
O
N N
N
N
Me
Et Cl
CO
NH
NH2 + R1-COOH POCl 3
N
N
Me
Et Cl
O
N
N
R1
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2.       D.Ramesh and B.Sreenivasan12  have synthesized 1,3,4-oxadiazoles from
          semicarbazide in presence of POCl3.
N
N
CH3
NH
O
NH NH
O
CH3
POCl 3
Ref. 4 hr.
N
N
CH3
NH
O
N
N
R
(VI)
3.      K.Mogilaiah and B.Sakram13  have prepared 1,3,4-oxadiazole from
          acetophenone-2-trifluoromethyl-1,8-naphthyridine-3-carbonyl hydrazone in
         presence of acetic anhydride.
N N CF3
NH
O
N CH3
Ar AC2O
N N CF3
N
N
O
Ar
CH3
CH3
O
      (VII)
BIOLOGICAL EVALUATION
2,5-Disubstituted-1,3,4-oxadiazole derivatives have been tested for various
pharmacological activities, which have been summerised as under.
1. Antibacterial14
2. Antiinflammatory15
3. Analgesic 16
4. Antiviral and anticancer17
5. Antihypertensive18
6. Anticonvulsant 19
7. Antiproliferative 20
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8. Antifungal21
9. Cardiovascular22
10. Herbicidal23
11. Hypoglycemic24
12. Hypnotic and Sedative 25
13. MAO inhibitor26
14. Insecticidal27
Some 1,3,4-oxadiazoles possessing insecticidal activity were synthesized by
Xiumian Zheng et al. 28  Takahiko Inoue et al. 29  have reported oxadiazole useful as prolyl
aminopeptidase inhibitor. H. Liszkiewicz. et al. 30  have screened oxadiazoles for their
antimicrobial activity. A.El-Azzouny et al. 31  have synthesized 1,3,4-oxadiazole derivatives
and evaluated for their analgesic, antiinflammatory, ulcerogenic effects and inhibitory
activity on plasma prostaglandin E2 (PGE2) Level.
Virginija Jakubkiene et al. 32  have screened 1,3,4-oxadiazoles for their
antiinflammatory activity. Song Cao et al. 33  have investigated some oxadiazoles possessing
insecticidal activity. S. Guniz Kucukguzel et al. 34  have discovered oxadiazole derivatives
and reported their antimycobacterial activity. Ali Almasired et al. 35  have prepared 1,3,4-
oxadiazoles of type (VIII) as anticonvulsant agent. Meria Grazia Mamolo et al. 36  have
synthesized 3-substituted-5-(pyridine-4-yl)-3H-1,3,4-oxadiazole-2-one of type (IX) and
studied their antimycobacterial activity.
O
N
N
O
NH2
F
N
O
N N
O
X
(VIII) (IX)
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N
N
O
F
Cl Cl
R
O
O
N
N
F
R
      (X) (IX)
Joshi et.al. have synthesized 1,3,4-oxadiazoles having substitution of aryl
sulphonamido42  and aryl43  at 2-position (Y) and 4'-pyridyl, benzenesulphonamido phenyl,
di-iodoquinolinoxy and aryl sulphonamide phenyl at 5-position (X) as antimicrobial
agents. H.H.Parekh and co-workers have prepared 1,3,4-oxadiazoles having substituted
triazine 44  phenyl sulphonyl45  2-isopropyl-5'-methylphenoxymethyl46  moieties at 5-position
(X) and aryl, arylamino, arylsulphonamido, substituted banzalamino moieties at 2-position
(Y) and screened for their antimicrobial activity. General structure for above references
are as under.
Sahin G. et  al. 37  have reported antimicrobial activity of oxadiazole derivatives.
Maslat A.O.et al. 38  have documented antibacterial, antifungal and genotixic activity of
bis-1,3,4-oxadiazole derivatives. Mida Malvina Buruliene et al. 39  have investigated some
oxadiazoles as anti-inflammatory agents. K.Subrahmanya Bhat et al. 40  have prepared
new fluorine containing 1,3,4-oxadiazoles (X) and reported them as potential antibacterial
and anticancer agents. T.P.Mohan et al. 41  have synthesized 2,5-disubstituted-1,3,4-
oxadiazole derivatives (XI) and screened for their insecticidal activity.
O
N N
X Y
NX =
, SO2NH ,
SO2NH.R
,
Aryl
NH-SO2-RY = , Aryl , -SH , -NH2 , -NHCO-R , -N=CH-R
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Recently, Ronald Kim et al. 47  have discovered oxadiazole derivatives useful
as protease inhibitors. Mohd Amir and Kumar Shikha 4 8  have documented
antiinflammatory, analgesic and ulserogenic activity of some newly synthesized
oxadiazoles. Ali A.et al.49  have investigated some oxadiazole derivatives possessing
antimicrobial and anti-HIV -1-activity. Sherif A. et al. 50  have reported oxadiazoles as
potential antitumor and anti-HIV agents. Afshin Zarghi et al.51  have synthesized R-
substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles (XII) possessing anticonvulsant
activity. Mahamud Tareq  et al. 52  have synthesized 2,5-disubstituted-1,3,4-oxadiazoles
(XIII) useful as tyrosinase inhibitors.
N
N
O
O
NH2
F
N
N
N
O
Br
(XII) (XIII)
In view of the potential biological activities of 1,3,4-oxadiazole ring system,
it was of interest to us to prepare some new derivatives of this family of heterocyclic
ring which have been described as under.
SECTION-I :       SYNTHESIS AND BIOLOGICAL SCREENING OF 2-
        (m-CHLOROPHENYL)-5-ARYL-1,3,4-OXADIAZOLES
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SECTION-I
SYNTHESIS AND BIOLOGICAL SCREENING OF 2-(m-CHLOROPHENYL)-
5-ARYL-1,3,4-OXADIAZOLES
Oxadiazole derivatives have been drawn the attention of chemist due to
diversified biological activities associated with it. In view of these facts, it was
contemplated to synthesize some newer oxadiazole derivatives with better potency.
Oxadiazoles of type (X) have been prepared by condensation of m-chlorobenzohydrazide
with different aromatic acid in presence of POCl3.
Cl
NH
NH2
O
R-COOH
POCl 3
Cl
N
N
O
R
Type (X)  R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.10.
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 Observed
Alkane C-H str. (asym.) 2937 2975-2950 53
  -CH3 C-H str. (sym.) 2845 2880-2860 53
C-H def.(asym.) 1475 1470-1435 53
C-H def.(sym.) 1379 1385-1370 53
Aromatic C-H  str. 3065 3080-3030 54
C=C str. 1509 1585-1480 54
C-H i.p. (def) 1120 1125-1000 54
C-H o.o.p. (def) 830 835-810 53
Triazole C=N str. 1634 1650-1580 54
C-N str. 1120 1220-1020 54
N-N str. 1035 1050-1010 54
Ether C-O-C str.(asym.) 1245 1275-1200 55
(Ar-O-R) C-O-C str.(sym.) 1037 1075-1020 55
Halide C-Cl str. 750 800-600 55
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 2-( m-CHLOROPHENYL)- 5-
METHOXYPHENYL-1,3,4-OXADIAZOLE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
 
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
%T
600.0800.01000.01200.01400.01600.01800.02000.03000.04000.0
1/cm
 750.0
 830.3
 960.0
1037.0
1085.0
1120.0
1227.6
1245.0
1293.2
1379.0
1475.4
1490.0
1509.2
1536.2
1604.7
1634.6
2845.0
2937.4
3065.6
3115.8
3342.4
3379.18 0
Cl
N N
O
OCH3
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NMR SPECTRAL STUDIES OF 2-( m-CHLOROPHENYL)- 5-
METHOXYPHENYL-1,3,4-OXADIAZOLE
1 3.92 3H singlet Ar-OCH3     -
2 3.8 3H singlet Ar-OCH3     -
3 6.93-6.97 2H doublet Ar-Hj,j’ Jji=9.6
4 7.31-7.37 3H multiplet Ar-H(a,c,e)     -
5 7.34-7.46 1H doublet -CHk Jkl=15.9
6 7.46-7.57 2H triplet Ar-H(b,d)     -
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
Cl
N N
O
OCH3
d
e
f
c
b
b' a'
a
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MASS SPECTRAL STUDIES OF 2-( m-CHLOROPHENYL)- 5-
METHOXYPHENYL-1,3,4-OXADIAZOLE
Expanded aromatic region of NMR spectra
Cl
N N
O
OCH3
d
e
f
c
b
b' a'
a
Cl
N N
O
OCH3
M/Z= 288
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EXPERIMENTAL
SYNTHESIS AND BIOLOGICAL SCREENING OF 2-(m-CHLOROPHENYL)-
5-ARYL-1,3,4-OXADIAZOLES
 [A] Synthesis of m-chloro benzohydrazide.
A mixture of methyl  3-chlorobenzoate (1.70g, 0.01mol) and hydrazine hydrate
(2.0 ml, 0.02 mol) in ethanol was refluxed in water bath for 2 hrs. The reaction mixture
was poured onto crushed ice. Crude product was isolated and crystallized from ethanol.
 [B] Synthesis of 2-(m-chlorophenyl)-5-(p-methoxyphenyl)-1,3,4-oxadiazole.
A mixture of m-chloro benzohydrazide (1.70g, 0.01mol) and p-methoxy
benzoic acid (1.52g, 0.01mol) in phosphorous oxychloride (10 ml) was refluxed for 6
hrs. The content was cooled, poured onto crushed ice and neutralised with sodium
bicarbonate solution. Crude product was isolated and crystallised from ethanol. Yield
64% , m.p. 1800C Anal. Calcd. for C15H11ClN 2O 2  : C, 62.43 ; H, 3.87 ; N, 9.77 %
Found : C, 62.40 ; H, 3.85 ; N, 9.74 %.
Similarly other oxadiazoles have been prepared. The physical data are
recorded in table No. 10.
 [C] Antimicrobial activity of 2-(m-Chlorophenyl)-5-aryl-1,3,4-oxadiazoles.
Antimicrobial testing was carried out as described in Part-I, Section (D).
The zones inhibition of the compounds are recorded in Graphical Chart No.10.
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                                             [B]
STUDIES ON
PHENYLAMINO DERIVATIVES
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INTRODUCTION
Phenyl amino derivatives have been found to be potent drug in pharmaceutical
industries and possess a wide spectrum of biological activity. Different types of phenyl
amino derivatives shows variety of pharmacological activities such as antibiotic, antifun-
gal, herbicidal, insecticidal, antitubercular etc. Phenyl amino derivatives have a special-
ity is that aniline moiety is electron donor as compared to that of aliphatic amino group.
Aryl amino molecules are chromophore with characteristic of absorption and
emission spectra, due to the conjugation between the nitrogen lone pair electrons and
the phenyl p -electrons. N-Alkyl or N-phenyl substitution of aromatic amines leads to
superior performance in material chemistry such as hyper polarizability1 ,
electroluminescence,2-3 etc.
4-Phenyl amino derivatives are also model of the polyaniline polymer.4 The
remarkable properties and its dual fluorescent derivatives of this molecule  have fascinated
chemists and tremendous effeorts have been devoted to understand their behaviour. 5-13
SYNTHETIC ASPECT
Different methods have been cited in literature to synthesize phenyl amino
derivatives by several workers using various interesting substactes.
1.        Eul Kgun Yum and co-workers14  have synthesized phenyl amino derivatives (I)
by the reaction of different anilines and the compound, which was obtained by
the reaction of diethyl malonate and triethyl orthoformate or triethyl orthoacetate.
    R1= H or CH3
    R2= OCH3, OCH2CF3, OCH2-CH2-OCH3
(I)
EtO OEt
O O R1C(OEt) 3
AC2O
EtO OEt
O O
R1 OEt
NH2
R2
EtO OEt
O O
R1NH
R2
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2.         Jin Sung Kim and co-workers15  have synthesized 6-chloro-7-phenyl amino-5,8-
phthalazinedione derivatives (II) by the condensation of 6,7-dichloro-5,8-
phthalazinedione with different aromatic amines in presence of CH3CN and cerium
(III) chloride hexahydrate.
(II)
BIOLOGICAL EVALUATION
Phenyl amino derivatives have been tested for various pharmacological activities,
which have been summerised as under.
1.       Antitubercular16
2.       Antifungal17
3.       Anticancer18
4.       Herbicidal19-21
5.        Antibiotic 22-24
6.       Cardiovascular25
Jin Sung Kim, Kyung Ho Yoo and co-workers26-28 have prepared phenyl amino
phthalazine derivatives (III, IV) and reported them as biologically active heterocycles
particularly as an anticancer agents.
N
N
O
O
Cl
Cl
NH2
CH3CN
CeCl 3. 6H2O
N
N
O
O
Cl
NH
N
N
O
O
Cl
NH
N
N
O
N
OR 2
N
OR 1
(III)     (IV)
    R
1
= Me  R
2
= Et
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Mauleon D, Pujol M.D., Rosell G29  have synthesized some new 4-aryl amino
derivatives and reported their biological activity. Bakhite EA, et al30  have synthesized
phenyl amino derivatives and documented their antibacterial and antifungal activity. Wen-
Fq Kuo and coworkers 31  have synthesized some new 4-aryl amino-1,2,3-triazoles (V)
and reported their biological activity.
        R= 4-OC 2H5, 4-OCH3   (V)
        R1= 4-CH3, 4-Cl
Satyanarayana D et al32  have synthesized 4-phenyl amino derivatives and reported
their antimicrobial and anti-inflammatory activity. Renaud Capdeville and Alex Matter33
have developed some new phenyl amino derivatives (VI, VII, VIII,IX) and proved them
as an anticancer agents.
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Bucsh RA et al. 34  have synthesized some new aryl amino derivatives and tested
for their antimicrobial activity. Hagen SE and co-workers35  have synthesized aryl amino
derivatives and reported their antibacterial activity. G.W. Rewcastle et al36 have
synthesized some new 4-(phenyl amino)pyrimidine derivatives (X,XI,XII,XIII) and
reported them as ATP-Competitive Protein Kinase inhibitors with potential agents for
cancer chemotherapy.
(X)          (XI)
(XII)      (XIII)    R= Br, OH
Hong CY  and co-workers 37  have reported antibacterial activity of some aryl
amino derivatives. Imamori K  et al. 38  have documented antibacterial activity of aryl
amino derivatives. Hyae Gyeng et al. 39  have synthesized some new phenyl amino
derivatives (XIV) and documented them as Gastric H+/K+-ATPase inhibitors.
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    R1= OCH3, OCH2.CF 2
    R2= H, CH3
(XIV)     R3= OEt, COOEt
Looking to this significant biological activity of 4-aryl amino derivatives, it was
subject of interest to study some 4-aryl amino derivatives which have been described as
under.
SECTION-I       : SYNTHESIS AND BIOLOGICAL SCREENING OF 4-
(ARYLAMINO)-PENT-3-EN-2-ONES.
SECTION-II       : X-RAY  CRYSTALLOGRAPHIC  STUDY OF  4-
(2-HYDROXY PHENYLAMINO)PENT-3-EN-2-ONE.
N
NH
CH3
R3
R2
R1
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SECTION-I
SYNTHESI S AND BIOLOGICAL SCREENING OF  4-(ARYLAMINO)PENT-3-
EN-2-ONES.
4-Aryl amino derivatives represents one of the modest class of compounds
possessing wide range of therapeutic activities . In views of these findings, it appeared
of interest to synthesize 4-(arylamino)pent-3-en-2-ones. The synthesis of phenyl amino
derivatives of type (XI) have been undertaken by the condensation of acetyl acetone
with different aromatic amines in the presence of pyridine.
Type (XI)  R=Aryl
The constitution of newly synthesized compounds have been supported by using
elemental analysis, infrared and 1H nuclear magnetic resonance spectroscopy and further
supported by mass spectrometry. Purity of all the compounds have been checked by
thin layer chromatography.
All the compounds have been screened for their in vitro biological assay like
antibacterial activity towards Gram positive and Gram negative bacterial strains and
antifungal activity towards Aspergillus niger at a concentration of 40 µg/ml. The
biological activity of the synthesized compounds have been compared with standard
drugs. Some compounds have been found to have moderate activity as compared to
known antibiotics recorded on Graphical Chart No.11.
R
NH2
+
CH3
O
CH3
O NH
R
CH3
O
CH3
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 Observed
Alkane C-H str. (asym.) 2924 2975-2950 76
  -CH3 C-H str. (sym.) 2860 2880-2860 76
C-H def.(asym.) 1459 1470-1435 76
C-H def.(sym.) 1358 1385-1370 76
Aromatic C-H  str. 3060 3080-3030 77
C=C str. 1502 1585-1480 77
C-H i.p. (def) 1045 1125-1090 77
C-H o.o.p. (def) 835 835-810 77
Hydroxy -OH str. 3389 3400-3200 76
Amine -NH str. 3457 3500-3400 77
Carboxyl -C=O str. 1669 1750-1665 78
-C-O-C str. 1174 1200-1150 78
Type     Ref.
        Reported
Frequency in cm-1 Vibration
Mode
IR SPECTRAL STUDIES OF 4-(2-HYDROXY PHENYLAMINO)-PENT
-3-EN-2-ONE
Instrument  : SHIMADZU-FT-IR 8400-Spectrophotometer ; Frequency range : 4000-400 cm-1
(KBr disc.)
 
0.0
20.0
40.0
60.0
80.0
%T
500.0750.01000.01250.01500.01750.02000.03250.0
1/cmdushyant crystal phenyl amino
 460.0
 549.7
 584.4
 597.9
 628.8
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 948.9
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1502.444 91599.8
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3300.9
3389.7
3457.2
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NMR SPECTRAL STUDIES OF 4-(2-HYDROXY PHENYLAMINO)-PENT
-3-EN-2-ONE
1 1.83 3H singlet -C-CH3     -
2 2.06 3H singlet -COCH3     -
3 5.17 1H singlet =CH     -
4 6.84 1H triplet of -CHa                  Jab=9.0
doublet                                       Jac=3.0
5 6.96-7.02 2H multiplet -CHb,c     -
6 7.17 1H triplet of -CHd                  Jdc=9.0
doublet                                       Jdb=3.0
7 8.75 1H singlet -NH     -
8 11.71 1H broad -OH     -
singlet
Signal
  No.
Signal Position
    (d ppm)
 Relative No.
  of protons
Multiplicity Inference    J Value
    In Hz
Instrumental Standard : TMS; Solvent: CDCl3 ; Instrument : BRUKER Spectrometer (300MHz)
OH
NH CH3
O
CH3
a
b
c
d
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MASS  SPECTRAL STUDIES OF 4-(2-HYDROXY PHENYLAMINO)-PENT
-3-EN-2-ONE
Expanded aromatic region of NMR spectra
OH
NH CH3
O
CH3
a
b
c
d
OH
NH CH3
O
CH3
M/Z= 191
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EXPERIMENTAL
SYNTHESI AND BIOLOGICAL SCREENING OF 4-(ARYLAMINO)PENT-3-EN-
2-ONES.
[A] Preparation of  4-(2-hydroxy phenylamino)pent -3-en-2-one.
A solution of 2-amino phenol (1.09 gm, 0.01 mole) and acetyl acetone (1.00 gm,
0.01 mole) in methanol (20 ml) was stirred for 12 hrs. in the presence of few drops of
pyridine at room temperature. The reaction mixture was allowed to stand at room
temperature for 24 hrs. The content was pour in to ice-cold water. The solid separated
was filtered and washed with water and recrystallized from methanol. Yield 64%,
m.p.170 oC. Calculated for C 11H13NO 2: C, 69.09; H, 6.85; N, 7.32;  found: C, 69.07;
H, 6.87; N, 7.30%.
Similarly other aromatic amines were condensed. The physical constants are
recorded in Table No.11.
[B] Antimicrobial activity of  4-(arylamino)pent-3-en-2-ones.
Antimicrobial testing was carried out as described in part-I, Section-I (D). The
zones of inhibition of compounds are recorded in Graphical chart No.11.
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SECTION-II
Single crystal X-ray Diffraction analysis
Single crystal X-ray diffraction is the most common experimental method of
obtaining a detailed picture of a small molecule that allows resolution of individual atoms.
It is performed by analyzing the diffraction of x-rays from an ordered array of many
identical molecules. Many molecular substances, including proteins, polymers and other
solidify in to crystals under the proper conditions. When solidifying in to the crystalline
state, these individual molecules typically adapted as one of only a few possible
orientations. A crystal is a three dimensional array of those molecules that are held together
by Van der Waals and noncovalent bonding. The smallest representative unit of this
crystals is referred to as the unit cell. Understanding the unit cell of these arrays simplifies
the understanding of a crystal as a whole.
Growth and Characterization of 4-(2-hydroxy-phenylamino)-pent-3-en-2-one
(HPAP) Crystal:
N-Phenyl, especially N-Benzyl amino acids find applications in peptide synthesis
and are valuable building blocks for the synthesis of chiral compounds40 .  The development
of 4-(3 ’, 5’-dibromo 4 ’-hydroxyphenyl) amino-6,7-dimethoxy quinazoline 41  has provided
the basis for new treatment as well as prevention programs for allergic asthma. Owing
to the medicinal properties of hydroxyl-phenyl amino derivatives, the crystal growth of
organic material 4-(2-hydroxy-phenylamino)-pent-3-en-2-one  (HPAP) has been carried
out. A part from the crystal structure determination and different characterizations such
as photoconductivity measurement and NLO test have also been carried out.
Phenylamino...
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 Growth of HPAP Crystals:
In the present study, acetone and methanol both were selected as solvents;
however, methanol yielded good quality single crystals. The seed crystals were grown
from controlled evaporation of saturated solution of HPAP in methanol and good quality
crystals were picked up for growth. A glass jar of 4 cm diameter and 7 cm length was
selected as a crystallizer. This jar was kept in a water bath with temperature control of
+ 0.1 0C. Water in the bath was stirred slowly. Supersaturated solution of HPAP was
poured into crystallizer and a seed crystal was hung by using very fine nylon thread. The
temperature of the water bath was maintained at 40 0C and the evaporation rate was
carefully controlled.
Figure [1]: Photograph of the grown HPAP crystals
Good quality single crystals with maximum dimension 1.5 cm X 0.75 cm were obtained.
Figures [1] show the types of crystals grown. The crystals were yellowish brown in
color.
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 Characterization of HPAP Crystals
 Single Crystal X-ray Diffraction and Structure Determination
The three dimensional intensity data were collected on an Enraf-Nonius CAD-4
diffractometer. The reflection data were collected at 293 K and ? /2? scan mode was
employed for data collection by using MoKa radiation (l  = 0.71073 Å). The structure
has been elucidated by direct methods using SHELEX 9742 . All non-hydrogen atoms of
the molecule were located from the E-map. Isotropic refinement of the structure by
least squares methods using SHELEX 9743  was followed by anisotropic refinement of
all the non-hydrogen atoms.  All the hydrogen atoms were fixed stereochemically. Atomic
scattering factors were taken from International tables for crystallography (1992 Vol. C
Tables 4.2.6.8 and 6.1.1.4). Geometrical and other structural calculations were performed
by using PARST44  programme. The experimental details and other measurement data
are given in Table [I]. The atomic coordinates and anisotropic displacement parameters
of the non-hydrogen atoms are given in Table [II] and geometry of intra and intermolecular
hydrogen interactions are given in Table [III]. The bond lengths and bond angles are
given in Table [IV]. An ORTEP diagram of the compound with atom numbering scheme
is shown in figure [2] and figure [3] represents the packing diagram of HPAP crystals,
which showing the hydrogen-bonding network45 .
Figure [2] : ORTEP Diagram of HPAP Crystals
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Table [I]
Crystal data from single crystal XRD
   Crystal data and experimental data.
    Formula                                                     C11H13NO 2
       Relative formula weight                            192.23
    Crystal system                                          Orthorhombic
    Space group                                               P2 12121
        Cell dimensions                                        a = 8.839(3)Å
                                                                     b = 10.517(2)Å
                                                                     c = 11.223(3)Å
    Z                                                               4
    V                                                              1043.4(5)Å 3
        T                                                              293(2) K
    Dx                                                            1.224 Mg/m3
      m                                                              0.084 mm-1
       ?max                                                                       24.95
o
      Radiation (Mo K a)                                      l=0.71073 Å
    Crystal Size                                              0.3 x 0.2 x 0.3 mm
    F (000)                                                      412
    Total no. of reflections                              1095
    No. of independent reflections                   1078
    No. of observed reflections                        1079
    No. of parameters                                      128
    R-value                                                     0.0425
    Rw                                                            0.1211
    Refinement method                                  Full- matrix least- squares on F2
    Goodness-of-fit on F2                                 1.043
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Table [II]
Atomic coordination of non-hydrogen atom of HPAP crystals
Atomic coordinates (x 10 4) and equivalent isotropic thermal parameters
(Å2 x 103) for non-hydrogen atoms
   Atom                    X                           Y                         Z                       Ueq
*
    O1                  4531(2)                 6847(2)                8517(2)               55(1)
    O2                  0807(2)                 7068(2)                9604(2)               54(1)
    N1                  1977(3)                 5782(2)                7819(2)               40(1)
    C1                  -0309(4)                4410(3)                7765(3)               57(1)
    C2                  -1712(4)                4127(3)                8227(4)               70(1)
    C3                  -2280(4)                4813(3)                9156(3)               65(1)
    C4                  -1468(3)                5800(3)                9641(3)               55(1)
    C5                  -0072(3)                6120(2)                9177(2)               41(1)
    C6                  0517(3)                 5424(3)                 8216(2)              41(1)
    C7                  2593(3)                 5780(3)                 6732(2)              42(1)
    C8                  4032(3)                 6224(3)                 6552(2)              46(1)
    C9                  4953(4)                 6765(3)                 7444(3)              44(1)
    C10                6472(4)                 7294(4)                 7122(3)              68(1)
    C11                1679(4)                 5332(4)                 5685(3)              66(1)
Ueq
*= (1/3)åiåj?Uij ai
* aj
*
 ( ai .aj)
    (?/s )max                                                                                        0.005
    (? ?)max                                                                  0.204 e. Å
-3
     (??)min                                                                                                            –0.179 e. Å
-3
        Measurement:                                         ENRAF-NONIUS DetectorProgram
    Program system:                                      ENRAF-NONIUS  Program
    Structure determination:                           SHELXS97
    Structure drawing:                                    ORTEP III
    Refinement:                                             SHELXL97
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Table [III]
Geometry of intra and inter molecular hydrogen interactions
   Geometry of intra and inter molecular hydrogen interactions.
            X-H...A             H...A(Å)             X...A(Å)             X-H...A( o)
         O2-H2…O1          1.831(2)              2.650(1)              176.5(2)
        N1-H1…O1( i)         1.934(1)              2.639(3)              138.4(1)
                            Equivalent position: (i)  -x-1/2, -y+3/2, -z+2
Table [IV]
Various bonds and bond length of HPAP crystals
     Bond lengths (Å) and bond angles (o)
               Bond Lenghts (Å)
               O1-C9               1.263(3)               C3-C4               1.375(5)
               O2-C5               1.352(3)               C4-C5               1.381(4)
               N1-C7               1.336(3)               C5-C6               1.403(4)
               N1-C6               1.416(4)               C7-C8               1.370(4)
               C1-C2               1.377(5)               C7-C11             1.502(4)
               C1-C6               1.389(4)               C8-C9               1.410(4)
               C2-C3               1.363(5)               C9-C10             1.498(5)
               Bond Angles ( o)
              C7-N1-C6          131.2(2)               C1-C6-N1         124.7(3)
              C2-C1-C6          120.1(3)               C5-C6-N1         116.2(2)
              C3-C2-C1          120.4(3)               N1-C7-C8         120.9(2)
              C2-C3-C4          120.7(3)               N1-C7-C11        119.7(3)
              C3-C4-C5          120.1(3)               C8-C7-C11         119.4(3)
              O2-C5-C4          124.0(3)               C7-C8-C9          124.6(3)
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              O2-C5-C6          116.4(2)               O1-C9-C8          122.3(3)
              C4-C5-C6          119.6(3)               O1-C9-C10         118.0(3)
              C1-C6-C5          119.1(3)               C8-C9-C10         119.7(3)
Figure [3] :   Packing diagram 4-(2-hydroxyphenylamino)-pent-3-en-2-one
  showing the hydrogen-bonding network
 Description of the Crystals:
The phenyl ring has geometry, which is more or less similar to its standard values
46-47. The bonds distances, O1-C9 and N1-C7, are shorter than the normal expected
values and the variation of this kind in the value of bond distances has been observed in
case of some analogous structures46-49. The small value of N1-C7 [1.336(3) Å] in
comparison to C6 [1.416(4) Å] results into significant variation in C7-N1-C6 bond
angle [131.2 (2)0]. The difference in C-N bond distances could be due to presence of
carbonyl group located at C9 position. Shorting of C7-N1 bond length and a large value
of the C-N-C bond angle leads to the existence of N1-H1…O1 intramolecular H- bond
50 . The magnitude of torsion along C6-N1 bond is 35. 3 0. The torsional deformation in
other bonds of the side chain is insignificant. The oxygen atom O2 is deviated significantly
below the plane of phenyl ring [deviation being -0.823 (2) Å] and it results in the formation
of O2-H2…O1 intermolecular interaction. The crystal structure is stabilized by an intra
molecular N1-(amino)-H1…O1 (one) and inter molecular O2-H2…O1 hydrogen
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bond which falls in the range of ‘intermediate hydrogen bonds’ as proposed by Desiraju
and Steiner50 . Both kinds of interactions are depicted in the unit cell-packing diagram
figure [3] in which the molecules are held together through a hydrogen-bonded network.
The intramolecular bond results into a virtual six membered ring thus making the present
molecule look like as two ring structure. The molecule exhibit typical orthorhombic
symmetry. In both the interactions, O1 acts as a bifurcated acceptor atom whereas O2
and N1 act as donors. The details of hydrogen bonding is shown in Table [III].
Using compiled data for a large number of O-H…O and N-H…O  contacts,
Desiraju and Steiner50  have found significant statistical directionality and concluded that
these are legitimately viewed as ‘intermediate’ hydrogen bonds, with a greater contribution
to packing forces than simple van der Waal interactions.
 Photoconductivity and NLO Studies of HPAP Crystals:
Polished sample of the HPAP was attached to a microscope slide and two
electrodes of thin copper wires were fixed by the use of silver paint. The distance (d)
between the electrical contacts was 0.112 cm. The sample was connected in series to a
d.c. power supply and a picoammeter (Keithley 480). The details of the experimental
set-up used in the present study are reported elsewhere51 . The applied voltage was
increased from 0 to 300 V in the steps of 20 V and the corresponding dark current was
recorded. The sample was then exposed to the radiation from a 100 W halogen lamp
containing iodine vapour and tungsten filament. The emission spectrum of the halogen
lamp was observed to be a continuous one with wavelengths ranging from 300 to 1000
nm. The photocurrent was recorded for the same range of the applied voltage. Figure
[4] shows the field dependence of dark and photo currents of HPAP crystals and Table
[V] gives the data of dark current and photocurrent for HPAP crystals.
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Figure [4] : Field dependent conductivity of the HPAP crystals
Table [V]
Photoconductivity Studies of HPAP Crystals
Voltage (V)                  Dark Current (nA)  I                  Photo Current (nA)  Ip
              20                          0.68            0.71
              40                          1.16            1.25
              60                          1.64            1.87
              80                          2.10            2.49
              100                          2.55            3.01
              120                          3.00            3.12
              140                          3.50            3.61
              160                          3.99            4.28
              180                          4.28            4.80
              200                          4.80            5.00
              220                         5.30            5.60
              240                         5.60            6.10
              260                         5.95            6.30
              280                         6.10           6.55
              300                         6.30           6.79
              320                         6.55           6.80
              340                         6.79           7.10
              360                         6.92           7.12
              380                         7.20           7.23
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It can be noticed from figure [4] that both dark and photo currents increase
almost linearly for HPAP crystals but the dark current is less than the photocurrent,
which is known as positive photoconductivity. Photoconductivity is explained in detail
by Joshi 52 . Photoconductivity was also reported in pure and doped L-argenin phosphate
(LAP) crystals by Pragasam 53 . This type of behavior of photoconductivity is due to the
increasing number of charge carriers or their life time.
Non-Linear Optics  (NLO) is the experimental set-up or the apparatus in which
the linear input results in non-linear output . Before the advent of lasers, transparent
optical materials were assumed to be passive, that is, unaffected by light traveling through
them. The high powers of Laser beams made it possible for the first time to observe that
the presences of light can, in fact, affect the medium. Intense light can change the refractive
index of absorption of the material. When this happens, the light itself is affected by the
change, in a nonlinear way. This can convert Laser in to harmonics of higher orders, i.e.
into different colors. This was first observed by Franken et al. 54  in 1961.
In the case of linear optical transitions an electron absorbs a photon from the
incoming light and does a transition to the next higher unoccupied allowed state.
Figure [5] : Formation of SHG from the crystals
 
Figure [5-a] Figure [5-b]
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When this electron relaxes it emits a photon of frequency less than or equal to
the frequency of the incident light [Fig. 5-a]. Second harmonic generation (SHG), on
the other hand, is a two photon process where this excited electron absorbs another
photon of same frequency and does a transition to yet another allowed state at higher
energy. This electron, on having transition back to its original state, emits a photon of a
frequency which is two times that of the incident light [Fig. 5-b]. This results in the
frequency doubling in the output 55 .
The non-linear optics is traditionally introduced by considering that the dielectric
susceptibility ? can be expanded in a Taylor series in terms of oscillating optical field.
The term ?1 is the dielectric susceptibility measured at low powers. The term  ?2, linear in
the field, multiplies the incident optical field, generating second harmonic frequencies.
The term  ?3 is quadratic in the field, producing third harmonic frequencies or introducing
a change in the index of refraction. There is a close relationship between ?2 and electro-
optic effect. In that phenomenon, an applied electric field multiplied by the optical field
creates an index change through the ?2 term, so that the index of refraction is controlled
by an external applied field 56 . Chelma and Zyss57  have compiled detailed information on
this phenomenon and materials observing that.
Materials, which possess optical nonlinearities, have been studied extensively
for their possible applications in various fields, for example, telecommunication, optical
computing, optical data storage and optical information processing58-60. Organic NLO
materials are, generally, more versatile than their inorganic counterparts due to their
more favorable nonlinear response, but these substances are often formed by weak van
der Waals and hydrogen bonds and hence possess a high degree of delocalization61 .
Many organic crystals are well known for their potential NLO applications, such as p-
hydroxyacetophenone 62 , benzoyl glycine 63 , hippuric acid 64 , etc. Recently, Dhanuskodi
and Vasantha 65  and Dhanuskodi and Manikandan66 , have reported the growth of
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semi-organic NLO materials, L-aluminium oxalate and methyl-p-hydroxy benzoate,
respectively. However, these crystals have inherent limitations such as increased optical
absorption, narrow transparency window and poor mechanical and thermal stability. On
the other hand, the inorganic NLO crystals have excellent mechanical and thermal
properties but possess relatively modest optical nonlinearties because of the lack of ð -
electron localization. Potassium dihydrogen phosphate (KDP)67 , ammonium dihdrogen
phosphate (ADP) 68 , lithium niobate69 , potassium penta borate 70  etc., are well known
inorganic NLO materials. Combining the high optical nonlinearity and chemical flexibility
of organics with temporal and thermal stability as well as excellent transmittance of
inorganics, a new class of semiorganic materials has been developed, which is attracting
a great deal of attention in the nonlinear optical field 71-72. L-Histidine tetrafluoroborate
(L-HFB) is a semiorganic NLO material, having SHG efficiency five times greater than
KDP 73 . There are many other semiorganic materials with potential SHG efficiency, for
example, amino-acid salts; L-arginine phosphate monohydrate74  and zinc cadmium
thiyocynate (ZCTC)75 .
In the present study, NLO properties of the HPAP crystals were measured by
measuring the second harmonic generation (SHG) efficiency. The crystal was evaluated
by the Kurtz and Perry powder technique using a Q-switched, mode locked Nd:YAG
laser. A microcrystalline material of KDP was used for the comparison purpose with
HPAP sample in the SHG measurements. The fundamental laser beam of 1064 nm was
used as a source. For a laser input pulse of 6.2 mJ, the second harmonic signal (532 nm)
of 23 to 24 mV and 275 mV were obtained through HPAP and KDP crystal, respectively.
Thus the SHG efficiency of HPAP crystal was nearly one tenth of KDP crystals. But the
NLO properties can be increased either by proper doping of the suitable material or by
making the proper inorganic salt of HPAP.
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